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ABSTRACT
An experimental study was performed to develop and validate a collection and analysis
protocol for human skin emanations. The protocol developed included the rubbing of
glass beads on the palms and backs of hands for 20 minutes. The volatile headspace
above samples were extracted by a solid-phase microextraction fiber which incorporated
a composite coating of liquid polymer matrix and solid porous particles. This protocol
provided robust and convenient signatures of human skin emanations and was applied to
two experiments for validation. In one experiment, a set of twins donated samples and
results suggested qualitative differences between samples of twins. The second
experiment involved collections from four unrelated individuals over a period of one
month. Multivariate analysis was applied to this data set and indicated a stable signature
that can be ascribed to the individual, confirming that the protocol developed here can be
extended to larger sample sets of MHC typed individuals.
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1. INTRODUCTION
This thesis focuses on developing a robust skin emanation collection and analysis
protocol for use in studying volatile compounds found in human skin emanations. A
collection method for this rarely-sampled body effluent was established to capture a
robust biological signature using convenient techniques amenable to collecting large
numbers of samples from many individuals. Also, the final sample needed to retain most
of the biological chemicals present on the skin while still meeting constraints on
collection time. In short, the analytical procedure needed be effective and efficient,
making an engineering approach to this biological research problem very helpful. The
final collection and analysis protocol for skin emanations was then tested on a large
sample set of emanations collected from multiple individuals over time. We tested the
hypothesis that the chemicals found in skin emanations were unique enough and also
invariant over time to allow for separation of individuals by a chemical "odor
fingerprint." This was shown using both experimental computational models and a
conventional multivariate analysis of the compounds present. In the following sections,
relevant background material from immunology, dermatology, and computational data
analysis is covered. In the next section, the protocol development is discussed to shed
light on the decision making process resulting in the final protocol. In the final section,
the results from two experiments, a monozygotic set of twins and four unrelated
individuals, are reported and used to validate the usefulness of this protocol. Future
applications and work are briefly discussed.
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In 1974 it was first suggested that human odor might be linked to specific
polymorphic genes such as the major histocompatibility locus[1], a set of genes that
control and enable the adaptive immune response. Since then a variety of studies-
behavioral, chemical, and genetic in nature-have been conducted, and several
hypotheses for a possible link have been proposed. With the advent of powerful
computational techniques for data analysis and its application to proteomics, or broad-
spectrum genome expression, entirely new kinds of research are now possible to
elucidate the origin of human odor. A complex, multivariate "odor phenotype" or
intermediate along the path to expression can be computationally modeled and analyzed
for patterns of chemical components. Based on experimental design and selection of
samples, models can be correlated with underlying factors, such as genetic sequence. In
contrast to traditional studies where a large number of variables are rigorously defined
and controlled from the outset and sample numbers are often limited, these new discovery
based techniques leverage the power of computational methods with sensitive analytical
instrumentation and rely on large sample numbers which capture as much biological
variability as possible. While some of these studies are seeing application in clinical
medicine, expansion into other areas of biological research is possible.
1.1 Adaptive Immune System
1.1.1 Major Histocompatibilty Complex
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The human major histocompatibility complex (MHC) is a region of approximately 4 Mb
of DNA located on the 6th chromosome, comprised of some 200 genes[2]. The
importance of this locus was first realized when tissue transplants were becoming a
standard medical procedure, and compatibility between donors and recipients became an
important concern. Interestingly, this issue arose specifically when physicians were
trying to treat burned aircrew in World War II, and skin grafts were frequently
rejected[3]. The original suggestion of self-presentation antigens occurred near the turn
of the century, though, in the context of tumor transplantation research in mice[3].
However, this research was largely unnoticed, and it was not until the war that the MHC
region was regarded as important. Since that time, more details of the MHC have been
elucidated and discovered in a variety of species[4]. Of particular note, the human MHC
is named HLA, also known as Human Leukocyte Antigen which is based on its
intertwined discovery with blood group antigens. This region was also observed in other
mammalian species, and in the mouse genome the MHC region is named H-2. Known
functions for the locus include coding for cell-surface proteins present in every cell of the
body which, under normal conditions, identify the cell as "self' to T-cells of the immune
system. These MHC products (MHC molecules) are anchored in the cell membrane and
present short peptides from the interior of the cell. In the event that a cell is infected, the
MHC molecules would present a foreign antigen that would be recognized by the T-cell,
targeting the cell for the immune response. In contrast, antibodies, located on the B-cells
of the immune system and in circulation, can recognize and bind foreign antigens readily,
without the process of presentation by MHC molecules.
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MHC molecules are divided into two categories, Class I and Class II. Class I molecules
are present in all nucleated cells of the body, and their purpose along with other MHC
products is to process and present foreign antigens for recognition by cytotoxic T-cells
(CD8 T-cells). Class II molecules are present only on certain lymphocytes, i.e. dendritic
cells, macrophages, and B-cells. Their purpose is to present antigens for recognition by
other effector cells, e.g. helper T-cells, which amplify the immune response through
release of cytokines and activation of B cells. Non-nucleated cells in the body, e.g. red
blood cells, express little or no Class I or Class II molecules. This is presumably due to
the fact that non-nucleated cells cannot be a host for invading viruses or intercellular
pathogens. The malaria plasmodium being a notable exception, which spends part of its
life cycle within erythrocytes, and its evasion of detection during this phase is, in part,
made possible by the lack of MHC presentation molecules.
In addition, the processing and presentation pathway within the cell is different for
antigens that will be presented on Class I versus Class II MHC molecules. Antigens
destined for Class I presentation start out in the cytosol of the cell, whereas antigens
destined for Class II presentation are picked up by endocytosis by the specialized
immune surveillance cells from extracellular space. They are conjugated to the MHC
Class II molecules through a different route in the endosomes of the cell.
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Class I MHC molecules are composed of an alpha-chain consisting of 3 domains[5]. The
first two domains form the peptide binding cleft which consists of two alpha-helices on
top of an anti-parallel beta-sheet. MHC Class I molecules can accommodate peptides
ranging from 8 to 10 residues in length[5]. Compared with the MHC Class II molecules,
C-terminal and N-terminal ends of antigens bound in the MHC Class I cleft are
significantly buried[5]. The third alpha-chain domain resides closest to the cell-
membrane and is attached to the membrane spanning sequence. A fourth domain, the 32 -
microglobulin, is non-covalently associated with the alpha-chain, and it is an invariant
subunit not encoded within the MHC.
Class II MHC molecules are composed of two chains (a and ) both of which span the
membrane. These two chains are non-covalently associated with each other[5]. Again, a
similar peptide binding cleft is formed by the first domain in each chain (a 1 and 3 1), and
the cleft consists of two alpha-helices on top of an anti-parallel beta-sheet. It is important
to note that the two halves of the peptide binding cleft are formed by parts of two chains
which are non-covalently associated, whereas in the Class I case the cleft is formed by
different regions of one chain that are covalently linked. Because of these structural
differences, the Class II peptide binding cleft is more open at the ends and, therefore can
accommodate peptide segments of much greater length, typically 10-20 residues in
length[5].
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When an antigen peptide is bound in the binding cleft both the peptide and the bordering
alpha-helices of the cleft are in extended conformations. Therefore, the antigen peptide
and the MHC molecule mutually stabilize each other through binding. This feature is
necessary to ensure stable and tight association between the peptide and the MHC
molecule. If the peptides were able to disassociate and bind freely with the MHC cleft,
than exogenous peptides could be picked up from extra-cellular spaces and result in
targeting of a non-infected cell by the immune response.
These known functions and structures of the MHC molecules have been the starting point
for possible theories connecting human odor to the MHC locus.
1.1.2 Haplotypes and Conserved Extended Haplotypes
The genes of the human MHC are quite diverse, with some genes having hundreds of
possible alleles. The numbers of alleles (identified as of January 2004) for human MHC
genes are given in Figure 1 below [1]. This polymorphism is in accordance with the
function of the immune system. Such variety is necessary to ensure an ability to adapt to
numerous pathogens and provide for the continuance of the species. Interestingly,
despite the polymorphism, it has been observed that certain combinations of alleles have
been well conserved in large populations across generations. While most of these studies
have been conducted in developed, western populations these conserved combinations of
alleles, or conserved extended haplotypes (CEHs), seem to be specific for ethnicity and
18
nationality. For instance, in the American-Caucasian population, seven specific
haplotypes show up with a frequency greater than 1%[6].
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Figure 1: Number Alleles Identified for HLA-A (left) and HLA-D (right) MHC Genes
The alleles typically differ at select residues along the peptide groove. While most of the
residues are located in the alpha-helices bordering the groove, some polymorphic
residues are also located on the beta-sheet forming the floor between the helices. The
residues generally form charged pockets that associate with amino acid side chains in the
antigen peptide. Certain specific patterns of amino acids are recognized by any one
groove, so the MHC molecule can bind a family of antigens, related by a pattern in their
sequence (for example, ... N-N-P-N-N-N-P-N-N-A..., could be a pattern where N stands
for non-polar residue, P for polar residue, and A for acidic residue).
1.1.3 Origin of MHC Related Volatiles
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The role of olfactory cues in the animal world is well established and recognized.
Animals use odors to communicate a broad range of characteristics such as sex, age
group, reproductive status, and identity[7, 8]. More generally, an "odortype" has been
defined as a secondary genetic trait, comparable to other modes, such as visual
recognition (human), used to convey important societal information[9]. Several
hypotheses have been proposed to explain the pathway from the HLA and MHC
polymorphic genes to the odor phenotype. Volatile signatures of blood, urine, and skin
emanations have been correlated to MHC types, mainly in mice, but also in rats and,
more tentatively, humans[7, 9]. Initially, studies of H-2 inbred mice suggested that
odortypes might be related to the MHC. These studies involved trained mice in a Y-maze
that could distinguish odors of other mice, who differed only at the H-2 locus. Later,
studies were conducted using mice that had not been trained. Instead, the habituation and
dishabituation behaviors of the mice to a series of odor signals were monitored. In these
murine studies, filtered and derivatized urine samples were the biological fluid of interest.
Mixtures of volatile carboxylic acids have been found to occur in urine and contribute to
odor cues in mice[10], as well as in skin secretions of mongooses[8]. These results have
been extended to protease-treated serum, under the assumption that volatiles are
conjugated in the serum and need to be liberated to form the volatile signature[9].
Another interesting idea is that volatile signatures are related to human MHC genes, but
not necessarily to the classic A, B, C, and D loci with known antigen presentation roles.
Another set of class I genes exist, E, F, and G, the allelic distribution and function of
20
which have not been nearly as well-studied[ 11]. These genes would be inherited along
with and in the same manner as the classical MHC genes. Once more is known about
these genes and their products, possible mechanistic details between MHC and odor
could be further illuminated, or ruled out.
The "carrier" hypothesis of the origin of odor was proposed based on the known function
of MHC products, to bind and present small peptide fragments (i.e. antigens in an
infected cell). It was shown that MHC molecules were present not only in cell
membranes, but also free in circulating plasma[12]. This seems reasonable since active
immune surveillance requires continual turn-over of MHC-ligand complexes. In the next
step of the pathway, these MHC molecules would be filtered out by the kidneys and
released into the urine. However, these large proteins have a low vapor pressure, so it is
unlikely they contribute directly to the volatile "odor" signal. On this basis, it has been
proposed that the MHC molecules associate with small molecules while in circulation,
e.g. small metabolites, or other wastes, and carry these through the kidneys and into the
urine. Once in the urine, and after excretion from the body, the molecules denature, or
otherwise change conformation, releasing the smaller volatiles into the atmosphere,
creating a unique volatile odor. The nature and relative proportions of these volatile
components would be dependent on the MHC molecules and their production and
assembly, therefore ultimately derived from the MHC genetic code. The direct
conjugation of volatile carboxylic acids (the one set of compounds that has been
correlated to MHC type in mice) with the MHC molecule is unlikely, since the MHC
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peptide groove is intended for larger, conformation-specific peptides. However, some
carboxylic acids, such as phenyl acetic acid, have been identified[10] and are known to
conjugate with amino acids, such as glycine and taurine, and so including this additional
conjugation step in the mechanism is necessary.
1.2 Background Literature for Skin Emanations
1.2.1 Anatomy of Human Skin
The skin is the largest organ in the human body and serves a variety of critical functions.
Throughout this study, the skin has been approached as a boundary between the organism
and the environment, which facilitates maintenance of the organism's internal
equilibrium. Most obviously, it is a barrier to the outside world, and the first line of
defense against infection and colonization by pathogens. Also, it can serve as a reservoir
for excess water, salt, and metabolic byproducts. Specific to humans, the skin serves an
efficient thermoregulatory function through perspiration, i.e. water is excreted onto the
surface and absorbs energy through heat as it evaporates. Finally, the skin can often be
an indicator of internal status, e.g. the pale color often assumed during illness, reduced
turgor indicating dehydration, and odors related to a spectrum of conditions from typhoid
to schizophrenia [7, 13, 14]. A variety of cellular, sub-cellular, and supra-cellular
structures combine to meet the disparate requirements of this organ and vary according to
anatomical region. The following sections will highlight the pertinent details of these
structures.
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1.2.1.1 Extracellular and Cellular Structures
Human skin consists of three major layers of tissues, each of which can be further divided
into various sub-layers. The three main divisions are epidermis, dermis, and basal
lamina. The epidermis is the uppermost layer (nearest the exterior environment) and is
comprised of several strata (5 de facto layers) with differing compositions of keratin-
filled, dead cells, or keratinocytes. The stratum corneum (SC) is the outermost of these
layers. It contains the furthest differentiated, squamous keratinocytes, called corneocytes,
or horny cells. According to the current "bricks and mortar" model, these corneocytes
(bricks) are seeded into a lipid matrix (mortar) exhibiting complex phase behavior[15].
The current description of this phase behavior and the composition of the lipid matrix,
called the domain mosaic model, proposes regions of crystalline phase surrounded by a
fluid, liquid crystalline phase[16]. This organization of the matrix putatively accounts for
the semi-permeable nature of the skin. Limited diffusion can occur in the liquid
crystalline phase, and excessive water loss and absorption are avoided while retaining the
ability for mechanical flexibility[16]. This is presumably one reason the palms of the
hands and soles of the feet, where lipid secreting sebaceous glands are sparse, become
"waterlogged" after extended immersion in water while other regions of the skin do not.
In this sense the, albeit thicker, SC located on the soles and palms can also be thought of
as a more permeable region to the interior of the organism. While these lipids are
important, the skin tissue contains and excretes other classes of bio-molecules also, and
these will be discussed in a subsequent section.
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The dermis is the thickest layer, lying just beneath the epidermis and provides
many support functions for the epidermis. All of the glands and hair follicles are rooted
in this tissue. In addition, capillaries are imbedded in this tissue and supply nutrients to
the surrounding cells through diffusion from the capillary wall and into the tissue. The
dermis is also innervated and hosts cells of the immune system. In particular, Langerhaus
cells are multinucleated, dendritic cells thought to provide necessary antigen collecting
and processing functions. It has also been recently discovered that MHC Class I-ligand
complexes can be transferred to Langerhaus cells by surrounding keratinocytes through
gap junctions[17, 18]. The basal lamina underlies the two aforementioned layers.
Consisting of mainly collagen and laminin, this thin layer provides the boundary of the
organ and the structural support from which cells are further differentiated into dermal
and epidermal cells.
1.2.1.2 Secretory Glands: Apocrine, Eccrine, and Sebaceous
Three types of secretory glands exist in human skin-eccrine, sebaceous, and apocrine.
According to common usage, only the eccrine and apocrine glands are considered "sweat
glands", and sometimes even this term refers only to eccrine glands. Sebaceous glands
are not considered sweat glands, but can be more generally classed as secretory glands.
Since ultimately the substances under consideration in this study are derived from both
sweat glands and sebaceous glands, the term "skin emanations" has been adopted, rather
than sweat. Other terms in use include skin secretions, or exudates. However the term
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emanations was preferred as it more clearly captures the volatile nature of the signal
analyzed in this study.
While all three types of glands are found throughout the skin in aggregations that
produce secretions, a primary function of eccrine sweat glands is to cool the body during
vigorous work. During this perspiration, eccrine glands produce mostly water, which
evaporates to cool the skin, and some salts. Eccrine glands are located throughout the
body, with the highest concentrations (and the highest concentrations of any secretory
gland) located on the soles of the feet and palms of the hands. Eccrine glands are
cholinergically stimulated during vigorous work, but also can be stimulated (in the
palms) para-sympathetically during emotional stress. By contrast, sebaceous glands are
associated with hair follicles and continuously secrete oils, or sebum. This milky-white
secretion hydrates and preserves the natural tincture and health of the outermost layers of
keratinocytes as discussed above, but also plays a role in creating an odor signal[8, 14].
Sebaceous glands are distributed through the body, and are most concentrated on the face
and scalp. The third type of secretory gland found in skin is the apocrine gland. It is
commonly believed, due to the distribution of this gland, that it is primarily responsible
for scent production in social communication, although no human pheromones have been
identified yet[19]. These glands first develop during puberty and are androgenically
stimulated. They are located primarily in the axillae and ano-genital regions. Also, in
these areas, a hybrid apoeccrine gland has been identified that also develops during
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puberty. Now that the overall structure of the skin and the specific secretory glands have
been described, the composition of the resulting secretions will be covered.
1.2.1.3 Molecules in Skin Secretions: Lipids, Proteins, and Aqueous
Lipids in and on the skin tissue are unique compared to the vast majority of lipids within
the organism[20]. Lipids within the organism can be classified into two basic categories
based on their function: structure and storage. Lipids are the major structural constituent
of the lipid bi-layer which is critical in cellular and intracellular compartmentalization.
Other internal lipids, in the form of triglycerides, form a critical component of metabolic
energy storage. Skin lipids, however, have specialized functions, other than structure or
storage, and their chemical structures are accordingly unique.
The aqueous portion of skin emanations is primarily derived from the eccrine
sweat glands as mentioned above. This secretion consists of mostly water with some
dilute salts. The body maintains homeostatic levels of salts in the blood and fluids by
releasing excess salts through this aqueous secretion. In the case of the genetic disorder
cystic fibrosis, excess chloride ion is transported out of cells lining the lumen of the gland
due to a faulty ion transport membrane protein. The proteinaceous component of skin
emanations can be divided into two groups of molecules: a set of small, antibiotic
proteins (4-7 kDa) and a set of large serum derived proteins (50+ kDa). Soluble portions
of MHC Class I and Class II proteins have been identified in dilute eccrine secretions and
belong in the latter group.
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1.2.2 Collection Methods for Skin Emanations
Human sweat is a rarely-sampled body effluent, and not extensively analyzed for
chemical components. Both human urine and human plasma, for example, have
relatively straightforward and well-established collection and preparation protocols, and
the chemical composition is also well established. Analysis of human blood and urine
are important diagnostic tools for many conditions and illnesses, increasingly with the
emerging fields of bioinformatics and proteomics. For example, recent studies have
shown the viability of analyzing serum proteins for the early diagnosis of ovarian, breast,
and prostate cancers[21, 22]. This has been accomplished by analysis of protein
components and peptides via time-of-flight mass spectrometry (TOF-MS). Sophisticated
computer algorithms are then applied to these large and complex data. In effect, they are
mined for "biomarkers", or specific ratios of mass to charge values (m/z values), that
segregate the diseased state from the healthy state. Mass to charge values are, of course,
related to specific chemical structures and, therefore, proteins. Also of particular note, a
recent study was conducted where the mass spectrometer and computer algorithm were
replaced by the canine nose in the analysis of urine for detection of bladder cancer.
These studies are all the more exciting since early diagnosis of these diseases has a
marked effect on survival rates. Analysis of skin emanations may have the potential to be
an equally important diagnostic tool. Specifically, the skin is also a reservoir for
metabolic wastes, and so it would seem reasonable that small metabolites associated with
a disease state would likely be purged as waste. Regarding this waste excretion function,
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the skin is also a distributed organ, in contrast to the bladder. In a limited fashion, skin
emanations already are used in the clinic, for example, in diagnosing cystic fibrosis in
children. Collections methods though are tailored for specific needs-i.e. in the case of
cystic fibrosis the analysis specifically quantifies the concentration of chloride ions. No
standard collection protocol is present for collecting human skin emanations.
A variety of collection protocols from current literature were reviewed and
include the following: a condensed flow of nitrogen over arms and hands[23], washing of
the skin with solvents such as ethanol[24], and collection onto glass in a variety of
forms[25-28]. As implied above, another set of specialized collection methods has been
developed as a means of diagnosing cystic fibrosis. A few of these collection protocols
will be discussed below.
1.2.2.1 Flowing Nitrogen over Skin
Several studies used a volatile effluent collection device. This was a "home-made"
device into which the donor would place his or her hands. A flow of nitrogen gas was
passed through the interior of the chamber, over the donor's skin, and then cryo-trapped
in a liquid nitrogen cooled vessel. The advantages of this collection protocol include
being able to collect a true volatile signature directly, without the need for an
intermediate collection substance or absorbent. The disadvantages of this device include
its design and fabrication and the need to wash, or otherwise clean, the collection
chamber between donors. In addition, donors would then be required to come to a
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specific collection site for analysis of skin emanations, and the ultimate use of this
technology would not be portable or useful to a wide scientific audience.
1.2.2.2 Other Collection Methods
Other collections methods used in the literature include sweat droplet collection and
droplet collection with the MACRODUCT device[29]. Sweat droplets can be formed as
a result of strenuous exercise, or can be stimulated to form by pilocarpine, a cholinergic
compound applied to the skin surface. In one study[29], it was found that the
MACRODUCT device was able to collect a set of proteins that differed between sexes in
humans. Collecting the sweat droplets via direct collection into a vial, instead of using
the MACRODUCT device, were insufficient to allow for this discrimination of protein
patterns.
1.3 Analytical Methods Used for Skin Emanations
1.3.1 Methods for Sample Preparation and Introduction
The power and usefulness of GC-MS has been extended greatly by improvements in
sample preparation techniques. Conventional capillary gas chromatography usually
indicates small liquid samples of a few micro liters which are volatilized upon injection,
or samples which are in a gaseous state to begin with. However, a variety of techniques
have been created or adapted to meet the increasingly diverse needs of a growing user
community. Three of the options considered for this study-thermal desorption, static
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headspace, and solid-phase microextraction (SPME)-will be discussed below, with a
more detailed discussion of the latter, which was ultimately selected for all samples.
1.3.1.1 Thermal Desorption of Deposited Emanations
Thermal desorption is an important route for sample preparation in GC-MS. Solid or
liquid deposits on a substrate, such as glass or a SPME fiber are heated beyond their
sublimation temperature. The analytes are then transported into the carrier flow of the
instrument and become, at this point, similar to a standard liquid injection that has been
volatilized in the inlet. It is important to keep the flow path increasing in temperature. If
at any point before the detector the temperature dips below the dew point of the analyte,
it can condense back out of the vapor phase and be deposited in the instrument.
1.3.1.2 Static Headspace
Static headspace represents often a high-throughput and prevalent technique for sample
preparation in GC-MS. Headspace analysis relies on the vapor liquid equilibrium of
analytes, usually dissolved in organic solvents, but also water. In order for static
headspace to be useful, a sample has to have a significant portion of its components with
a high vapor pressure. More molecules can be volatilized by heating of the sample, or
mechanical agitation. It is often used in environmental studies and other standard,
routine GC-MS analyses. Static headspace was attempted in the initial studies, but skin
emanations were of such a low abundance that the instrumentation was not able to detect
a significant signal above random noise.
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1.3.1.3 Solid Phase Micro Extraction (SPME)
Solid Phase Micro Extraction (SPME) has become a useful and prevalent analytical tool,
especially for the analysis of volatiles. SPME usually implies that the extraction device
is in a polymer fiber form; however other forms are available such as the Twister®
device described in a later section. This section will discuss the history and theory
behind SPME, as well as the various applications, advantages, disadvantages, and special
considerations in using SPME for extraction of volatiles.
A variety of SPME phases are available commercially, and phases can also be
custom made for individual needs. Of particular relevance to this study, most volatile
extractions are best conducted with mixed phases that include poly(divinylbenzene), or
DVB. The DVB additive is usually present as solid, porous particles, seeded into a
matrix of a liquid PDMS phase. Another commercially popular option replaces the
PDMS matrix with Carbowax®, a poly(ethyleneglycol), or PEG, with an average
molecular weight around 20,000 amu. The increased polarity of the PEG over the PDMS
matrix increases slightly the affinity for polar compounds. However, most interactions of
volatiles will occur on the large surface area of the porous DVB particles through an
adsorption mechanism, rather than through a diffusion mechanism into the liquid matrix.
Therefore, these mixed phase fibers are more useful in extractions of volatiles over
condensed phases[30]. In addition, because of this adsorption mechanism, the extraction
times are significantly shorter as compared to the single phase fibers[31]. On the other
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hand, though, this mechanism also leads to a shorter dynamic range for the extraction and
increased competitive displacement[3 1].
1.3.2 Gas Chromatography and Mass Spectrometry (GC-MS)
1.3.2.1 Nature of Data and Sensitivity
The combination of a gas chromatograph for separation followed by mass spectrometry
for identification (GC-MS) is a powerful analytical tool that has become increasingly
refined and standardized over the last half century. For this study it is a proven
technology for detection of volatiles, but also provides a robust amount of data. The
mass spectrometer used for this study was an Agilent 5973N (Palo Alto, CA). In
quadrupole mass spectrometry (MS), chemical compounds are fragmented and become
charged by electron impact (chemical ionization is also possible). The masses are then
filtered by a scanning electric field and allowed to contact a detector which registers the
mass scanned by the filter and the charge transferred producing a mass-to-charge ratio
(m/z). Each compound has a unique fragmentation pattern, and a spectrum of masses can
be used for identification of chemical structure. Each spectra is correlated to the time
they are retained by the chromatographic column, or retention time (RT). A typical data
file consists of a RT axis, an ion count (abundance), and an m/z axis. Due to the large
and complicated data acquired, however, efficient and thorough analysis requires
methods borrowed from chemometrics, such as principle component analysis (PCA), and
genetic algorithms.
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1.3.3 Pattern Recognition by Genetic Algorithms
With the revolutionary development of computer processing and its subsequent
advancement in power and speed, genetic algorithms have become an increasingly useful
tool for multivariate optimization, machine learning, and neural networks[32]. Analysis
by genetic algorithms borrows its methods and terminology from biology, and these
analyses hinge upon self-evolving numerical models of natural systems, which are
inherently complex[33]. A genetic algorithm generates potential solutions to a problem
(chromosomes), judges each solution as to how well it solves the problem (determines the
fitness), and then generates a new set of solutions preferentially combining and
reproducing more fit solutions from the first set (recombination of fit chromosomes).
Each iteration of this process is considered a generation.
In this study, the problem is classifying a group of individuals based on the
mixture of volatile compounds in their skin emanations. As applied to the GC-MS data,
the solution (a chromosome) is a set of RT-m/z coordinate pairs (genes) that, in their
relative differences in abundances, are able to segregate the four individuals. A RT-m/z
coordinate pair is related to a specific chemical structure, so each gene can be connected
with a volatile component. For a simplified qualitative example, let's say that the four
individuals were readily classifiable by the presence or absence of a particular compound.
That is, person A's skin emits only compound A; person B's skin emits only compound
B; and so on. The solution might then be a chromosome whose genes were the
identifying RTs and m/z values for compounds A, B, C, and D. The relative abundances
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would be as follows in Table 1 for each individual, where a value of 1 is used to indicate
100% abundance since it is absent in samples from all other individuals. This solution
also applies to the more complex quantitative case, where all four individuals each emit
all four compounds, but in characteristic relative concentrations.
Table 1: Hypothetical Chromosome for Genetic Algorithm Classification
Compound A Compound B Compound C Compound D
Person A 1 0 0 0
Person B 0 1 0 0
Person C 0 0 1 0
Person D 0 0 0 1
The process of finding the solution is as follows. Data files from each sample are
randomly segregated into training data and validation data. The genetic algorithm begins
by randomly generating a population of chromosomes. Each chromosome's fitness is
determined based on how well its genes are able to classify the four sets of samples (from
person A, B, C, and D) used in the training data. The more fit a chromosome, the more
likely it will be selected to combine with another chromosome in the population to
generate two new chromosomes (offspring) in the next generation. After two new
chromosomes are formed, two will be removed (culled) from the entire pool to keep the
total population at a constant number. The less fit a chromosome, the more likely it will
be removed during this process. In this way, the entire gene pool is constantly being
refined to find the most fit chromosome available. As fit chromosomes join to create
offspring their genes can recombine so that new gene combinations can be generated.
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In the ProteomeQuest® genetic algorithm developed by Correlogic Data
Systems®, Bethesda, MD, user defined inputs include the number of genes per
chromosome, number of generations, and number of chromosomes. In addition, two
more inputs (match and learn) influence the spatial separation and combination of
chromosomes in the fitness space. The likelihood of re-combination occurring and the
likelihood of culling are finite probabilities derived from the fitness function.
Probabilities are used to incorporate an element of randomness, also a hallmark of natural
systems, to limit artificial fitting of a model to a set of data.
In 2002 Petricoin and Liotta described a rapid screening process for ovarian
cancer and prostate cancer that involved collecting serum samples from patients,
analyzing them by SELDI-TOF, and searching the data for biomarkers of cancer with the
ProteomeQuest genetic algorithm[21, 22]. Through this procedure, they reported 100%
sensitivity and 100% specificity for discriminating a diseased state from a non-diseased
state in ovarian cancer[34]. There is some discussion in the literature regarding the
confidence in these results[35-37], but the prevailing opinion regards this research as
novel and promising, and it can be complementary to well established disease
biomarkers, such as prostate specific antigen (PSA)[38-40]. The current discussion in the
literature will serve to standardize experimental procedures and analysis methods for
discovery based research in proteomics, which requires multivariate, computational
approaches. In effect, this represents another joining of disciplines under the broadly
applied term of bioengineering.
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1.3.4 Data Processing Concerns- Alignment of Retention Times
Pattern recognition techniques such as genetic algorithms and PCA are sensitive to small
shifts in RT[41, 42]. These RT shifts can confound building a proper model. For
example, a series of chromatograms belong to, in this case, samples from one individual,
and a specific component elutes at a RT of 20.00 minutes. However, over the set of
samples the RT shifts between 19.00 and 21.00 minutes, and this component will not be
used as a marker belonging to this individual due to this variation. The nature of these
RT shifts is due to random shifts in partitioning through the column and necessary
maintenance of the instrument which leads to trimming of the column is non-linear. In
order to account for this an alignment algorithm[43] was modified in MATLAB to
include reference files from four individuals. The code for this is given in the appendix.
2. MATERIALS AND METHODS
2.1 Initial Studies for Protocol Development
The majority of the experiments during protocol development were intended to reproduce
the results and verify the compatibility of the glass bead collection protocol as described
in the aforementioned studies of mosquito attractants[26]. However, a few other ideas
were also explored, and some of the results obtained will be highlighted. This will help
describe the developmental process resulting in the final protocol. Table 2 below gives a
summary of the experiments conducted during protocol development. The numbers refer
to the amount of samples collected and analyzed under the indicated protocol. The
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column on the left gives the types of substances considered for collecting the skin
emanations. The columns on the right give the various combinations of sample
preparation (SPME, headspace, or thermal desorption in the inlet) and analytical
instrument-FAIMS, flame ionization detector (FID), or mass selective detector (MSD).
The grayed out boxes indicate a collection-analysis combination that was incompatible.
Table 2: Summary of Experiments Conducted During Protocol Development
Collection Substance Sample Preparation and Analytical Instrument
SPME Headspace Inlet
FAIMS FID/MSD FAIMS FID/MSD MSD
Glass Beads 14 20 33* 17*
Silica Beads 4
Glass Beads, Heavy Sweat 4 2
Beads with Gloves 1 8
Filter Paper, Heavy Sweat 2
Inverted Vial 7 1
Sock Odors 6
Twister Stir Bars 8
2.1.1 Anatomical Locations for Sweat
As outlined in a previous section, secretory glands in the skin have variable distributions
throughout the body. In order to explore the nature of the volatile signature produced by
the body, experiments were conducted to focus on certain anatomical regions. Some of
these experiments involved adapting a collection onto glass beads to regions other than
the backs and palms of hands, e.g. forehead, face, and back of neck. These regions were
chosen because of the abundance of sebaceous glands found there. In addition, a few
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experiments were conducted using an inverted headspace vial, with its opening placed
snuggly against the skin, in a variety of locations. This idea was intended to directly
capture volatiles escaping from the skin surface, small volatiles that were perhaps being
missed by the other techniques. Most of these experiments proved inconclusive, but a
few are worth noting because of key considerations they provoked, i.e. sock odors,
induced perspiration, Twister® extraction, and glass beads rubbed on hands (which was
ultimately adopted as the final protocol). The experimental designs had to balance the
constraints of time and access to equipment with the most beneficial scientific payoffs.
Therefore, the following sections and initial results are not intended as a thorough and
rigorous characterization of variable body odors, but rather a logical and expedient search
for a robust, useful, and convenient volatile signature for skin emanations.
2.1.2 Collection Substances
2.1.2.1 Socks Worn on Feet for Three to Four Hours
To test the viability of collecting odors from fragments of clothing, an experiment
was designed and executed to analyze the odors produced from worn socks. Nylon socks
were selected since this material is less absorbent than cotton and, being synthetic, would
presumably have a less abundant organic volatile signature. The socks also needed to be
thin, in order to minimize the relative amount of foreign material and to facilitate
insertion into the vials used for analysis. Three donors volunteered to wear the socks for
three to four hours. Two sections were cut from each sock, and each segment was placed
38
into a 10 mL headspace vial for analysis. A circumscribed midsection of the sock was
selected in order to include both eccrine glands located on the sole and sebaceous glands
more abundant on the top of the foot. The toe section of the sock was selected in order to
collect from a region conventionally regarded as odiferous. Unworn socks were prepared
by the same method and analyzed to provide a background or control signature of
volatiles. In summary, the sock odors produced a complex signal of many overlapping
peaks. This achieved the desired robustness of the signal, but the background signal from
the socks themselves turned out to be significant. Due to potential confounding effects of
this high abundance background signal, a more inert substrate, such as glass beads or the
Twister SPME device was preferred. These two approaches will be described shortly.
2.1.2.2 Induced Perspiration by Exercise
Induced perspiration is a logical and obvious method for sweat collection, and a few
experiments were attempted to explore its viability. Three donors volunteered to collect
sweat after rigorous exercise. The donors were provided with two vials containing a
piece of filter paper, or a set of cleaned glass beads. The donors were instructed to wash
their hands after exercise, open the vial marked control and expose the filter paper (or
glass beads) contained within to the ambient air. The second vial was then to be opened.
The filter paper (or glass beads) was to be applied to the skin in a region with abundant
sweat and then returned to the vial which was then sealed. The vial containing the
background signature was particularly necessary since samples were being collected
offsite. In summary, samples from these studies provided a weak signal, presumably due
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to the dilute nature of induced perspiration. Most of this fluid is water, with small
amounts of electrolytes, and this accordingly enables its evaporative and thermal
regulatory function. From these experiments, it was determined that a collection protocol
which did not induce heavy perspiration, but rather passively collected the natural
secretions and emanations was preferred. This would minimize the relative amount of
water, which can be thought of as a stable matrix that would dilute and trap volatiles. In
addition, including exercise in the sample collection protocol would ultimately reduce the
number of samples that could be collected due to donor volition.
2.1.2.3 Twister® SPME device
The Twister® SPME device is a magnetic stir bar which has been coated in an unusually
thick layer of poly-dimethyl siloxane (PDMS), traditionally used in standard SPME fibers
and, also, chromatographic columns. The advantages of this device over standard SPME
is its ability to be immersed in a sample (either liquid or gaseous) and then agitated via a
magnetic flux, producing presumably a more robust and thorough extraction. In the case
of skin emanations, due to the thick nature of the PDMS phase, the Twister® device
could be grasped in the hand without significant damage to the PDMS phase. In the case
of a traditional SPME fiber, due to differences in processing and geometry, such handling
tends to destroy the polymer phase. Since the Twister® device could then be directly
desorbed in the GC inlet, the capability of being handled allowed direct extraction of skin
emanations from the hands of the subject, removing the intermediate headspace
extraction step involved in the other methods. However, the thick and robust nature of
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the PDMS phase is also a drawback in that collection times are significantly increased.
The extraction mechanism operates by diffusion into and out of the liquid polymer phase
and is much slower than that encountered in the traditional SPME fiber. A labeled
picture of the Twister® extraction device is given in Figure 2 below.
S -
Figure 2: Picture of Twister® PDMS Extraction Device
2.1.2.4 Glass Beads Rubbed on Hands
Rubbing of glass beads on the hands has been used extensively in studies of volatile
components which naturally attract mosquitoes to human hosts[26]. Borosilicate glass
beads, originally intended for culturing purposes, provide a fairly inert substrate on which
to collect human skin emanations. The beads chosen were 3 mm in diameter, which is
small enough to fit in a variety of devices for thermal desorption (as discussed in a
previous section), and yet big enough for the donor to handle without dropping. For a
collection, 30 beads were chosen as a median value. With more beads it becomes
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difficult and awkward for the donor to rub the beads in their hands. With fewer beads the
surface area on which to collect emanations is reduced. For a sample of 30 beads,
roughly 848 square millimeters (or 1.30 in2) is available to collect skin cells and
emanations. A picture of the glass beads used is given in Figure 3 below.
Figure 3: Picture of Glass Beads Used in Collection of Skin Emanations
2.1.3 Cryofocusing of Trace Volatiles and SPME Alternative
Skin emanations deposited on the glass beads presented difficulties for sample
preparation. In the aforementioned studies of mosquito attractants, the glass beads were
directly desorbed in the GC inlet. This technique was attempted and comparable results
to that found in the literature were obtained. However, directly desorbing the beads in
the GC inlet raised a few concerns. First, cellular components were present on the beads.
This was often easily verified by visual inspection of the beads after a 20 minute
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collection. White waxy flakes were found deposited on the beads and appeared to be
sloughed corneocytes. Desorbing these coatings of cells directly in the GC inlet raised
concerns that non-volatile cellular components were being volatilized, contributing
compounds otherwise not present in a volatile signature. In addition such sample
desorptions were inherently dirty for the instrumentation. Oftentimes, after retrieving a
desorbed sample from the inlet, the previously white coating on the beads was often
scorched and browned by the inlet temperature. Inlet liners had to be replaced after a few
analyses and could not be reused without first cleaning the glass, and then deactivating it
through a complicated and time-consuming process. Given the price of inlet liners, such
desorptions were not feasible for large sample sets. In addition, the standard GC inlet
installed in the instrument was not intended for this purpose. Temperature cycling of the
inlet and repeated opening and closing of the inlet cap would induce accelerated wear.
The temperature cycling itself became problematic, as it often took 1 to 1.5 hours for the
inlet to cool down from its upper temperature in order to start a new analysis.
Cryofocusing of the column was necessary for direct thermal desorption from the
beads in order to provide a high abundance signal for trace volatiles (see the diagram in
the Appendix for the instrument setup). Without cryofocusing of the column, the
volatiles would enter the column in trace amounts throughout the entire run and be
present in the resulting signal as a low broad peak nearly indistinguishable from the
baseline[44]. The technique involved immersing the column in a bath of liquid nitrogen
during the initial part of the run, i.e. the first 10 minutes. During this time the beads
43
remained in the closed inlet, and the inlet temperature was ramped to 250 C. After this
initial 10 minutes, the column was removed from the liquid nitrogen bath, wound back
around the column basket, and the door to the oven was closed. The temperature
programming for the GC analysis began, and the focused slug of analytes began to
partition and travel through the column normally. The inlet was operated in a splitless
mode, with a low flow of helium carrier gas, throughout the entire analysis.
However, it was discovered that the sub-ambient temperature of the liquid
nitrogen bath and the frequent temperature cycling of the GC method was damaging the
polar phase of the column. This was apparent by the severe drop in abundances and
exclusion of some peaks in the standard (mix of representative ketones) which was
analyzed by the GC on a regular basis to ensure proper instrument function. This column
damage was not observed on the non-polar HP-Sms column, but since the polar HP-
WAXetr column had been selected for all the biological samples to allow for comparison
(plasma, urine, skin emanations, and murine samples), a new extraction (or
concentration) method had to be explored. Previous experiments had shown the promise
of using solid-phase microextraction (SPME), and so an additional experiment was
conducted to show that SPME could produce results similar to that obtained by direct
desorption of the beads with subsequent cryofocusing. A summary of the results is given
in Table 3 below. Both qualitative and quantitative criteria were established to determine
the similarity between SPME and cryofocusing preparation techniques.
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Table 3: Summary of Results from SPME versus Cryofocusing Experiment
%.i
Person/ Total#
Day
1 , 22
I
2 ' 36
3 , 29
1 ' 16
2 ' 24
.
3 , 25
I
% in
Literature
64% (14)
28% (10)
38% (11)
56% (9)
17% (4)
28% (7)
Types of Compounds
CA, Aliph, Arom, Cholest.
CA, Aid, Aliph, Arom
CA, Aliph, Arom
CA, Aid, Aliph, Arom
CA, Aid, Aliph, Arom, Vit. E
Ace.
CA, Aid, Aliph, Arom, EtOH
Statistical Analysis
____________-
SPME controls were
more correlated to
SPME samples than
CRYO controls were
to CRYO samples;
both methods were
reproducible
Abbreviations: CA-Carboxylic Acid, Ald-Aldehyde, Aliph-Aliphatic, Arom-Aromatic, Vit.
EAce.-Vitamin E. Acetate, EtOH-Ethanol, Cholest.-Cholesterol
2.1.4 Gas Chromatography Columns and Methods
All skin emanation samples were collected and extracted as described above.
After adsorption onto the SPME fiber, the extracted volatiles were then desorbed into the
inlet of the gas chromatograph, and the GC/MS method for separation and identification
began. This method consisted of a 5 minute desorption of the SPME fiber at 2500 C. In
addition, the inlet was operated in a splitless mode, during which a relatively low helium
carrier gas flow passed through the inlet and into the column. During these five minutes,
the GC oven (and column) was set at 500C. Volatiles desorbing off of the SPME fiber
entered this helium gas flow and traveled to the top of the column mounted at the base of
the inlet. At the top of the cooler column, volatiles partitioned into the liquid phase and
formed a band just below the inlet. At the end of the initial five minutes, the inlet purge
valve was opened and the gas flow rate increased 50 fold to sweep any lingering volatiles
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SPME
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to the top of the column, or otherwise out the purge vent. At this point, the temperature
programming of the column began. Three temperature ramps were used to help better
resolve the complex spectrum of peaks. This method had been optimized for SPME
extraction of volatiles in a murine MHC study[45].
2.2 Selection of Donors
2.2.1 Twins and Other Samples Collected at CBR
Three sets of twins volunteered to collect skin emanation samples (according the
protocol described above) at the Center for Blood Research (CBR), Boston, MA, where
all of the blood and urine samples were also collected. All human samples were collected
with informed consent and approval of CBR institutional review board. In addition, CBR
determined the MHC-type of these donors. The data collected from these sets of twins
represents the initial MHC correlated data collected for skin emanation samples. The
MHC typing, as determined by CBR, is given in Table 4 below.
Table 4: MHC Typing of Twins-Skin Emanation Samples Collected at CBR
Donor Nos. Region MHC Type
Class I A*02 (a), A*03 (c), B*27 (a), B*07 (c), Cw*1O (a), Cw*07 (c)
10 & 11 Class II DRBl*11 (a), DRB1*15 (c), DQB1*03 (a), DQB1*06 (c)
Class III S?31 (a), S?31 (c)
12 & 13 Class I A*02, A*29, B*35, B*58, Cw*07, Cw*08
Class II DRB 1 *08, DRB 1* 11, DQB 1 *03, DQB 1 *04
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It should be noted that three other, MHC-typed individuals (unrelated) have had
skin emanations collected from them at CBR as well. One collection has occurred, so far,
for each of these donors. This acquired data will be useful in the future, as a larger data
set of skin emanation samples is eventually built up and correlated with MHC types.
2.2.2 Unrelated Individuals
Four unrelated individuals volunteered to provide samples of skin emanations
according to the collection protocol described above. Collections occurred twice daily, at
the same times each day, once in the morning and once in the afternoon. Occasionally, a
donor missed a collection, and a convenient time was arranged to conduct a make-up
collection. During each collection, a batch of unhandled beads was prepared, just as the
batches were prepared for each donor minus the actual collection of emanations, in order
to obtain a background signal for that collection. The donor group consisted of two
males and two females, ages 22-27, with no known health problems.
3. RESULTS
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Class III BF*F, BF*X, C4A*3, C4A*X, C4B*I, C4B*X
Class I A*31 (a), A*03 (c), B*44 (a), B*07 (c), Cw*03 (a), Cw*07 (c)
17 & 18 Class II DRB 1*01 (a), DRB 1*15 (c), DQB 1*05 (a), DQB 1*06 (c)
Class III F?31 (a), S?31 (c)
The goal of this study is to prove that the collection and analysis protocol described
above provides a robust biological signature of human skin emanations, and that this
process can be incorporated into MHC based studies of skin emanations including large
numbers of samples. The results of two experiments, four unrelated individuals and three
sets of twins, are presented below and described, qualitatively and quantitatively. Using
these results, the efficacy of the collection protocol is judged on the following criteria.
1. A robust signal is present above and beyond that present in the control samples.
2. Qualitatively this signal can be characterized as biological, consisting of
compounds reported in the literature and accepted as components of skin
emanations.
3. A large sample set can be collected over an extended period of time, and this data
can be modeled to remove day to day variations and extract a unique signature
that can be ascribed to the individual.
4. The signature of genetically related individuals can be qualitatively described and
characterized over multiple collections.
Also, in the process of the study, the interesting effect of competitive adsorption on the
SPME phase was observed during some of the multiple extractions conducted on samples
and will be highlighted.
3.1 Results from Four Unrelated Individuals Experiment
3.1.1 GC/MS Analysis
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Figure 4: Representative Total Ion Chromatogram (TIC) of Skin Emanations Sample
from Four Unrelated Individuals Experiment
Figure 4 above gives a representative response from the GC/MS instrument for a sample
of skin emanations collected during the four individuals experiment and extracted by the
procedures detailed above. As can be seen in the figure, a complex spectrum of peaks is
eluting through the column.
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Figure 5: Representative Total Ion Chromatogram (TIC) of Control Sample
Figure 5 above gives a representative volatile signature obtained from a sample of
cleaned and un-handled beads, referred to as a control sample. The large peaks eluting at
retention times (RTs) up to 15.00 minutes were compared to the NIST library (Version 2,
Build 1 July 2002) database of accepted mass spectra. These peaks were identified
readily as siloxane compounds characteristic of the SPME fiber, the column phase, or the
chromatograph's injector septum and, while undesirable, are difficult to avoid in this
analytical procedure. However, the majority of the volatile signature due to skin
emanations (comparing to Figure 4) appears to occur after a RT of 15.00 minutes, and so
co-elution, or at worst obscuring, of sample peaks by these background siloxanes is
limited to the initial period of time.
In order to make the complex spectrum of volatiles present in Figure 4 more
manageable and understandable, an ion of particular mass can be extracted from the total
ion chromatogram (TIC). Carboxylic acids re-arrange and fragment characteristically
between the alpha- and beta- carbons, producing a fragment of mass 60 amu. This is a
well studied phenomenon for carboxylic acids and other derivatives of fatty acids known
as the McLafferty rearrangement. An m/z value of 60 can be extracted from the complex
TIC given in Figure 4, and the resulting extracted ion chromatogram is given in Figure 6
below.
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Figure 6: Extracted Ion Chromatogram for Organic Acids in Skin Emanations Sample
As can be seen in Figure 6, a mixture of carboxylic acids is present in the
headspace above the beads, and the acids are eluting through the chromatographic
column in a specific sequence. As expected, the retention time is increasing with
molecular weight, since the molecules with the larger carbon backbone (all compounds
having otherwise the same carboxylate group) partition more slowly into the column
phase. This trend is summarized in Table 5 below, which gives the average values of the
RTs for four of the acids which appear in all 30 samples for each donor. Assuming a
normal distribution of retention times, the standard deviation across all 30 samples is
given with the mean value. In almost all cases, except for heptanoic acid, the RT is only
varying by 0.004-0.006 seconds. This corresponds to the length of time for one scan of
the mass range (50-550 amu in this case) by the quadrupole mass ion selector. Therefore,
this is really a discrete unit, and obtaining a more precise value is not feasible with the
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same acquisition parameters. That is, fragment ions for the particular carboxylic acid
could in fact be traveling through the quadrupole, but if this mass selector is not exactly
tuned to the relevant mass (which it passes only once per scan), then this species will not
reach the detector and be included in the ion count, even though it is in fact eluting during
this short time period. Heptanoic acid seems to have a standard deviation in its RT closer
to two scans, and this is perhaps due to its later RT and the increased opportunity for
dispersive effects to operate.
Table 5: Retention Times for Four Carboxylic Acids in Samples for Each Donor
Donor 4 Donor 5 Donor 7 Donor 9
Butanoic Acid 14.23 +/- 0.006 14.23 +/- 0.006 14.23 +/- 0.005 14.23 +/- 0.005
Pentanoic Acid 15.86 +/- 0.005 15.86 +/- 0.004 15.87 +/- 0.005 15.86 +/- 0.005
Hexanoic Acid 17.50 +/- 0.005 17.50 +/- 0.005 17.50 +/- 0.006 17.50 +/- 0.005
Heptanoic Acid 19.73 +/- 0.007 19.73 +/- 0.010 19.74 +/- 0.012 19.74 +/- 0.009
Such carboxylic acid mixtures (backbones ranging from C-5 to C-14) are
characteristic of biological samples and, when compared to the background signal from
the un-handled beads (Figure 5), provides confirmation that biological volatiles are, in
fact, being collected on the beads and subsequently extracted by the SPME fiber. The
target response (ion count abundance) for each of these carboxylic acids is summarized in
Table 6 below. The mean values, across all 30 samples for each donor, are given, but the
variability between each sample is quite significant. Assuming a random, normal
distribution, the percent variance ranges from 31% to 105%. This variability has a
number of sources, to include the inherent nature of biological samples. Organisms are
dynamically interacting with their environment at all times. Equilibrium is hard to define
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in these complex, multivariate, and ill-defined systems. Other sources of variation
include the experimental procedures.
Table 6: Target Response for Four Carboxylic Acids in Samples for Each Donor
Donor 4 Donor 5 Donor 7 Donor 9
Butanoic Acid 102144.07 46508.27 26560.33 44637.10
Pentanoic Acid 66422.73 42720.73 18240.30 38151.60
Hexanoic Acid 299504.50 486707.03 156532.50 422648.10
Heptanoic Acid 107472.83 219628.83 54044.00 172009.73
A slight tailing trend can also be seen for each peak in Figure 6, i.e. the back side
of each peak tails off asymmetrically. This peak tailing is characteristic of carboxylic
acids due to the resonance available to the carboxylate group and multiple available
interactions with the column phase. Conventionally, when analyzing carboxylic acids by
GC, they are first converted (derivatized) to their corresponding methyl esters. These
esters are less reactive with the polar phase of the column, and this derivatization leads to
narrower peaks and more reproducible abundances. However, derivatization was not
practical for the skin emanations samples, which were present as a thin coating on the
glass beads, and in addition attempting a chemical reaction on these heterogeneous
samples could have altered other, unidentified components and led to loss of sample, or
introduction of experimental artifacts. It is important to re-iterate that the results for only
a small subset of carboxylic acids has been extracted and presented here in order to
obtain a familiarity and understanding of the otherwise complex spectra.
3.1.2 Models Produced from Pattern Recognition
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As mentioned previously the large and complex data sets require an efficient and
effective analysis procedure. This current study is a fairly new application of such
GC/MS data (although, MS in general is becoming increasingly popular in proteomics
studies), and it was desirable to explore both standard proven analytical techniques, such
as PCA, and also more experimental techniques, such as the Correlogic genetic
algorithm.
Correlogic applied the genetic algorithms to the data set obtained from the
experiment on the four unrelated individuals described in preceding sections. In all,
thirty data files acquired from samples for each donor were prepared and submitted. All
files were aligned to a reference file as described above. Data files consisted of a three
dimensional matrix with retention time (RT), abundance (or ion count), and mass over
charge ratio (m/z) coordinates. Each data file, once converted to binary format and
aligned to the reference, was 14.6 MB, and a total of 1.75 GB of data needed to be
processed by the Correlogic system. This large amount of data was difficult for
Correlogic to process, and the comparison of 4 individuals simultaneously was
unprecedented. Therefore, Correlogic installed a new computing cluster and added the
functionality of simultaneous comparison of 4 states. Still models could only be built and
tested on limited subsets of data, truncating the RT range from the full 40 minutes.
Table 7: Correlogic Model #3121-98.3% Overall Accuracy
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Count of Predicted Actual
Predicted 0 1 2 3 (blank) Grand Total
0 14 14
1 1 15 16
2 14 14
3 16 16
(blank)
Grand Total 15 15 14 16 60
Table 7 above gives one of the most accurate models returned by Correlogic so
far. The basic method of model creation with genetic algorithms, in general, was covered
in a previous section. Specifically, though, in the Correlogic models, data files are
randomly segregated into training and testing sets. The training files are used to build the
model, while the testing files are used to validate the model once it has been built. In
Table 7, the validation results for the training files for each donor are given. In only one
case did the model miss-assign a file to donor 1 (donor B) which actually belonged to
donor 0 (donor A). Out of all 60 files, used for validation, this one wrong assignment
correlates to the high overall accuracy of 98.3 percent. The biomarkers, consisting of a
RT and m/z coordinate pair, were searched within the NIST library of target spectra in
order to identify the chemical compounds underlying these factors and will be discussed
in the following section.
Principal component analysis was conducted on this data set to verify the
classification produced by the genetic algorithm, and the resultant scores and loadings
plot is given in Figure 7 below. The figure gives the plot of the data as classified by the
two largest principal components. Each component is a linear combination of features
(chromatographic peaks) in the original data set that account for the greatest amount of
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variation between donors. Each marker (either circle, triangle, cross, or square)
represents a data file that was classified according to a model. By visual inspection, one
can obtain an idea of how well classified the data is. Similar data files are clustered
amongst themselves, while still reasonably segregated from other sets of data files. The
crosses correspond to donor A, the squares to donor B, the triangles to donor C, and the
circles to donor D. Upon further review of these PCA results, an artifact from the signal
processing seemed to be present. The clustering of data for donor B was unusually tight,
compared to the other donors. It was necessary to make adjustments to the alignment
algorithm in this case. This experience underscores the need to carefully handle the data
when using the genetic algorithm for analysis and the need to confirm exploratory data
analysis with more standardized and proven techniques. It should be noted, though, even
with the artifact introduced during the alignment, a high degree of separation is still
noticeable in the PCA model. It is merely the clustering that was affected by the
alignment algorithm.
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Figure 7: Scores and Loadings Plot from Original PCA
The alignment algorithm created in MATLABO was modified to account for
reference files from 4 individuals. All the files were then re-aligned, and the PCA was
repeated for this experiment. The scores and loadings plot is given in Figure 8 below.
As previously, the cross markers represent files classified according to the model for
donor A. The squares correspond to donor B-the triangles to donor C, and the circles to
donor D. The ellipses drawn around the markers are visual aides only and do not
represent any formal boundaries.
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Figure 8: Plot of Two Largest Principal Components from Revised PCA Analysis
To avoid the aforementioned truncation of the RT, an alternative approach was
explored. The m/z component of the data was removed for the model building. Models
were generated then on the ion abundance and RT data only (basically the TIC out of
each data file). Once specific biomarkers had been identified, occurring at a specific RT,
the corresponding m/z spectrum could then be investigated for chemical identification.
This alternative led to a more straightforward method for chemical identification, as well
as, the capability to include the entire RT abscissa in the construction, testing, and
validation of the models.
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3.1.3 Lists of Compounds Identified
In the Correlogic model that achieved 98.3% classification accuracy, nine biomarkers
were identified. The RT and m/z coordinate pairs for each biomarker were extracted
from each data file and compared to the NIST library database. The following
compounds, in Table 8 below, were identified at each of the nine biomarkers across
donor files.
Table 8: Compounds Identified at 9 Biomarkers in Correlogic Model #3121
RT
Compound Name (min)
1,2,3,4-Tetrahydroisoguinolin, 2-acetyl-6,7-dimethoxy-1-phenmethylene- 4.864
Cyclopentasiloxane, decamethyl- 6.593
Cyclopentasiloxane, decamethyl- 6.882
Rhodopin 7.591
(5.)Pregnane-3,20-diol, 14,18,.-[4-methyl-3-oxo-(1 -oxa-4-azabutane-1 ,4-diyl)]-, diacetate 8.033
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one derivative 8.390
Hexadecanoic acid derivative 16.281
Hexadecane, 1,1-bis(dodecyloxy)- 19.802
4a-Phorbol 12,13-didecanoate 28.084
The two siloxanes eluting at 6.593 and 6.882 minutes are components of the
column phase or SPME fiber matrix. It is unlikely two biomarkers are originating from
the column phase, the SPME fiber, or the vial septa which would have random variations
across samples. This is more than likely a mis-identification within the NIST library for
these biomarkers, or the background is obscuring the real compound for the library
identification. The other 7 compounds in the list have biologically related functions.
However, the matches of these compounds with the NIST library targets were not
conclusive. Therefore, the potential exists that these are biomarkers of unknown
chemical identity.
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3.2 Results from Twins Experiment
A series of multiple extractions was conducted on each sample from each twin.
This involved extracting the sample three times in immediate succession with a new
SPME fiber. The sample vial was maintained at the extraction temperature (65 C) as
one fiber was removed and a freshly conditioned fiber was inserted for the next
extraction. Three extractions were conducted on each sample, and representative total
ion chromatograms (TICs) for both a control sample of un-handled beads (Figure 9) and a
skin emanations sample (Figure 10) are given below.
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Figure 9: Representative Total Ion Chromatogram (TIC) from Control Sample- Twins
Experiment
As can be seen in Figure 9 above, the control beads possess a low level signal. The initial
peaks at a RT less than 15.00 minutes were readily identified in a NIST library (Version
2, 1 July 2002) search as siloxanes derived from the SPME fiber, the chromatographic
column, and the septum in the sealed 10 mL headspace vial. The larger peak at 17.8
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minutes is an unidentified contaminant that was present in most samples from CBR. This
is either a component of the CBR clinical environment, or a contaminant deposited on the
beads inadvertently while the beads were being prepared for collection. Due to the
ubiquitous nature of residue from the hands some level of contamination is unavoidable
in preparing samples, even though gloves were worn by the administrator.
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Figure 10: Representative Total Ion Chromatogram (TIC) from Skin Emanations Sample-
Twins Experiment
In Figure 10 above, a robust set of peaks is present above that indicated by the control
sample. Many of these peaks are co-eluting and overlapping which makes identification
via a NIST library search difficult.
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Figure 11: Overlaid TICs for Multiple Extractions- Twins Experiment
As can be seen in Figure 11 above, signal complexity and abundance exhibits a
general decrease as more extractions are conducted. Conducting qualitative searches
with the NIST library confirms this trend. Some components present in the first
extraction are too low abundance to be selected by the integrator and compared to the
library spectra database by the time the third extraction is conducted. Upon closer
inspection of the chromatograms, the reverse trend was also noticed. By focusing on the
extractions for one donor and manually searching the TIC across the RT, two compounds
were observed to be missing in the first extraction and showed a stabilizing trend in
subsequent extractions. The first compound was eluting at a RT of 15.758 min, and a
zoomed in region of the overlaid TIC at this RT is given in Figure 12 below.
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Figure 12: Overlaid TICs of Multiple Extractions for Donor 18
In the first extraction, the broad peak eluting at 15.780 seems to have been
concealing another peak to its left at 15.758 which becomes apparent only in the second
and third extractions, after the larger peak has been completely extracted. Also, the large
peak at 15.636 minutes shows a dramatic decrease between the first and second
extraction, but is relatively stable for the second and third extraction. The fact that some
peaks are completely extracted while others show a stable response after multiple
extractions indicates that equilibrium is being reached between the SPME fiber and the
volatiles in the headspace of the vial over the 30 minute extraction time. This is expected
based on the nature of the SPME phase. The polymer surface will interact with volatiles
in a preferential manner. Similar compounds, with similar polarity and solubility, will
adsorb more readily to the surface of the DVB particles and diffuse more easily into the
PDMS matrix. Over time as more collisions at the surface occur, the compounds with
higher affinity will start to replace those with less affinity. This will occur most readily
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for the adsorbed molecules on the surface of the DVB than for the molecules diffusing
into the liquid polymer. However, it highlights the issue of competitive adsorption for
the SPME-headspace interface, and suggests that a more representative spectrum of
volatiles could be captured under transient, non-equilibrium conditions. Such an
approach has been recently suggested which proposes that a diffusion based calibration of
such extractions while carefully controlling the air flow past the fiber can lead to more
quantitatively reproducible results[46]. This idea, considering the short time involved in
acquiring the volatile signal, is particularly interesting for designing a device for field
use, and such implications will be discussed in a later section.
Figure 13 below compares the two sets of twins for one collection. By following
the trace profile of the TICs one can find, in a qualitative manner, peaks that are unique
to one of the twin sets. The top two TICs correspond to donors 17 and 18 (one pair of
twins) while the bottom two TICs correspond to donors 12 and 13 (another pair of twins).
The red lines indicate peaks unique to the latter pair of twins. This was verified by
comparing the mass spectra across all four samples. The two peaks identified on the left
were not conclusively identified in the NIST spectral library, but the peak on the right,
eluting at 37.266 minutes was identified with high confidence as tetradecanoic acid. This
is encouraging because it is one of the aforementioned carboxylic acids known to be
biologically relevant and able to associate with MHC peptides. The target spectrum
compared with the NIST library spectrum is given in Figure 18 in the appendix.
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Often positive chemical identifications are a subjective judgment of the analyst. One_ 
must look at a variety of factors including RT and signal abundance, in addition to the
samples of interest, the more efficient these judgments become. However, compounds50we00re identifi d with the following criteria:
1. Quality of match with the NIST library target compound was greater than 702. Identified in all three extractions at RTs within 0.03 minutes of each otheri I
3. Not identified in any control sample (unhandled beads) at a comparable RT
The quality of match factor is a number generated within the Chemstation® software that
compares an unknown spectrum to a library target by taking into account ratios of ion    
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counts between m/z values, the absence of expected m/z values, and the presence of
potentially extraneous m/z values. It is a useful gauge in determining the overall match
of an unknown compound to a target in the library, and its range is from 0 to 99, the
upper limit indicating an identical match[47, 48]. The value of 70 was selected for this
analysis as a balance between opposing concerns. Lower values lead to a larger number
of poor matches and became increasingly difficult and unwieldy for analysis. A higher
value, though, could potentially rule out critical components. It must be noted that all of
these library searches are limited by the completeness of the library used. The NIST
library (Version 2, Build 1 July 2002) is a standard, extensive, and high-quality library,
but it still contains only 147,198 target spectra. The potential for missing important
components of the signal increases by requiring more accurate matches with library
targets.
Table 9: Shared Compounds Identified in Skin Emanations
Shared Compounds in Twin Pair 1
1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester
Decanal
Dodecanoic acid
Nonanal
Shared Compounds in Twin Pair 2
5,9-Undecadien-2-one, 6,10-dimethyl-, (E)-
Dodecanoic acid
Isopropyl Myristate
Octanal, 2-(phenylmethylene)-
4. DISCUSSION
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4.1 Importance of Skin Emanations as a Body Effluent and Metric
Currently, the sweat test is the most reliable method for diagnosing cystic fibrosis. It is
also popular because it is non-invasive and quick. Skin emanations in general have
potential for many applications in many fields to include homeland security and
medicine. In the past, odors emitted by patient have been a surprisingly good tool for
disease diagnosis. Furthermore, odor is a non-line-of-sight, latent tool for identification
as in the example of bloodhounds.
4.1.1 Confounding Factors
4.1.1.1 Diet, Health, Age, Gender, and Environmental Factors
Human samples (or any biological sample) are inherently complex. Living organisms are
constantly adjusting and dynamically interacting with their environment. Analyzing the
specific influence of such factors as diet, health, gender, or environment on a skin
emanations signature was outside the scope of this study. Rather, in order to reduce the
effect of such variables, a large sample set was collected over one month. Donors were
not asked to adhere to a certain diet, or make a specific change in their diet. The health
status of the donors was not monitored, nor controlled. The four donors were selected
from a limited age range (22-27) and consisted of two males and two females. Samples
were collected in the mornings and afternoons in order to capture any of the circadian
variability in one individual. Environmental factors include living conditions and non-
biological contaminants picked up from the surroundings. In order to limit this factor,
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skin emanations were collected from a single, confined anatomical area, and donors
washed their hands according to the established protocol and rinsed thoroughly prior to
every collection. Paper towels were not used, but hands were allowed to hang dry in the
air. All collections were conducted in the same laboratory setting with controlled access.
The critical factor in the experimental design, however, is the sample number and the
time span of collection. It is assumed that over a period of a month, a common
denominator will remain amongst all the day to day variability of the signature, and this
common denominator can be detected via a multivariate analysis technique. The
signature obtained thus can be ascribed to the individual, but not necessarily to any
specific "odortype" gene or locus. It is important to note also, applying the model
outside the sample group on which it was built would make no sense. This model is only
able to classify one individual compared to the other three in the model. The protocol
and method can easily be used on larger sample sets and more genetically specific
experiments in order to discover more specific underlying factors. Such efforts to extend
the generalizability of the model will be discussed in the following section.
4.1.1.2 Experimental Artifacts and Chance
When using experimental data analysis techniques, like genetic algorithms, the following
concerns are critical: bias, chance, over-fitting, and generalizability. These issues have
been discussed recently in reviewing advances of clinical diagnosis of cancers[38, 39],
but they are also applicable to this current study.
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Bias, or experimental artifacts, is an important problem in using such data
analysis. Bias occurs when an artifact is unintentionally introduced into the data, either
by experimental protocol, or data processing. In the event something like this occurs,
data could potentially be segregated, not based on the phenomenon of interest, but rather
on the spurious differences introduced by changing conditions. Once protocols were
finalized in this study no further changes were made during sample collection, or data
acquisition. Care was taken to carefully monitor instrument performance and
consistency. For example, through routine and inevitable maintenance the
chromatography column would need to be trimmed. This had to be done, or otherwise
the inlet liner would generate active sites and lead to other potential biases. As the
chromatographic column was trimmed (5-10 cm per month), a slight shortening of RT
would be expected. Overtime, this shift could become significant, and this is one of the
reasons the alignment algorithm was implemented. It must also be noted that samples
were run in the order they were collected, therefore a typical sample run would consist of
samples from all four donors so that no one donor's data was acquired all at once and at a
different time than the other donor's. Also, SPME fiber use had to be carefully
monitored. SPME fibers were routinely inspected for oxidation, and after a certain
number of uses had to be replaced. This trend also followed sequentially through the data
acquisition, and care was taken to ensure that not one SPME fiber was being used
exclusively on one donor's set of samples, thereby introducing potential bias. A good
example highlighted in the study of potential bias was the effect on clustering that the
alignment algorithm had. This was evident once the genetic algorithm results were
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compared to more traditional PCA, and underscores the need for comparison to proven
methods.
Chance can play a role in model creation in two ways-the model can fit a data set by
chance when no underlying markers exist (type I error), or the model can not fit a data set
by chance when underlying markers do in fact exist (type II error)[39]. Closely related to
false-negative and false-positive conclusions based on chance is the problem of over-
fitting. Over fitting occurs when an excess of underlying factors is presumed by the
model, and it is able to distinguish between two states based on the combinations of these
excessive factors. The more factors, or "biomarkers", there are to build a model, the
more likely a chance collection of those factors can classify the two states perfectly, and
the factors have nothing to do with the phenomena being analyzed. Therefore, one way
to check for the problem of over fitting in a model is to independently validate the model,
or have the model classify independent data that were not used in training, or building, of
the model. This is similar to using a control group in conventional experimental
design[38]. It is also important, in experimental design to use large sample sets and
specify few underlying factors in building the model. In this study such an approach was
followed. The validation results were presented earlier from the Correlogic genetic
algorithm. Validation was performed on sets of data that the model had not used in
building of the model, and it was able to successful classify these in several models.
Furthermore, since approximately 15 data files were used in the validation, the number of
factors was limited to no more than 9 (in the case of the model presented in the text). The
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fewer number of factors specified, the less the model is fitting by chance. Rather, the
more likely the model has hit upon the underlying factor related to the phenomena of
interest, in this case unique odor signature.
Generalizability is the most difficult problem faced by new pattern recognition
techniques. Essentially, a model built on data acquired in one study-using one
experimental protocol, with one set of subjects, and using one analytical instrument for
data acquisition-is not readily extendable when any one of these variables is changed.
This is a problem that everyone in this field must confront and is currently struggling
with. The solution for now is to continue expanding and collecting immense data sets
and boil down the models to the most fundamental, invariant common denominators.
For example, in this study, samples of skin emanations were collected over a period of 30
days. Models were built on this data. If new samples were to be collected after a period
of 6 months using the same collection, extraction, and analysis procedures, they could
then be validated with the model. If the model was able to maintain the same overall
accuracy as the original validation, but with the new set of data collected 6 months in the
future, then the generalizability of the model could be proven in part. That is, after a
period of extended time, the model was still able to accurately classify skin emanations
between four different individuals. This would be the first step of generalizability.
However, if the model's accuracy with the new data set was significantly reduced, then
the original model was built upon some transient, underlying factors that are no longer
effective 6 months later. It is not general enough. In this case, a new model can be
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generated from scratch, including the new data. The new validation accuracy could be
compared to previous models, to see if any improvements were made, and presumably
the model has been created based only on common factors between the original data set
and the new data set, effectively excluding the transient factors. A new data set could
then be generated at a future time and the process repeated.
4.2 Advantages and Disadvantages of Collection Method
The collection protocol presented here has important advantageous over other collection
protocols. First of all, skin emanations are a non-standardized biological fluid, and
developing the proper protocol can be time consuming. However, once it is established,
such collections are much more convenient, due to their non-invasive nature. Collections
from the palms and backs of hands are able to capture both the sebaceous secretions as
well as the eccrine secretions, both polar and non-polar components of skin secretions.
These secretions are known to produce odors and known to contain metabolic wastes
(e.g. excess salts and lipid metabolism). Apocrine secretions are more difficult to collect
and are co-located with sebaceous and eccrine glands. Therefore, in order to isolate the
apocrine component, one must isolate a single gland and stimulate a secretion.
Alternatively, incorporating a collection like the one described in this study, as part of a
larger study of skin emanations, is one way of comparing sebaceous and eccrine
secretions to combined (with apocrine) secretions. Certain disadvantages must also be
addressed. The SPME fiber extraction of the volatile signature will preferential exclude
certain compounds, based on the nature of the SPME phase. Therefore, while sample
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preparation is greatly simplified, only a subset of volatile components can be extracted at
one time. This is partially alleviated by the variety of phases commercially available, and
experiment design can include using several phases on one sample. At the same time,
SPME may be ideally suited for field applications as discussed in a following section.
SPME with automated extraction hardware can also be used for high-throughput analysis
with minimal supervision. This is particularly useful when sample sets are large.
4.3 Comparison of Compounds to Those Identified in Literature
Some of the compounds identified in the literature as components of skin secretions are
given in the tables below. Similar mixtures of carboxylic acids and other biological
compounds have been found in qualitative searches of the data obtained in this study.
This indicates that a complex biological signature, specifically skin emanations, is being
collected and characterized via this collection and analysis protocol. Such mixtures of
compounds are known to produce odors, and can be detected by conventional analytical
instrumentation, such as GC/MS.
Table 10: Compounds Identified in Literature
Carboxylic Apocrine
Acids[26] Secretions[50]
2-methylhexanoic
acetic acid
acid Hexanoic acid
3-methylhexanoic (E)-3-methyl-2-2-propenoic acid
acid pentenoic acid
dimethylsulfone 3-methylhexanoicpropanoic acid C2H6S02) acid(C2H6SO2) acid
2-butenoic acid (Z)-3-methyl-2-
y-C 8-lactone hexenoic acid
2-methyl-2-butenoic 4-ethylpentanoic Heptanoic acid
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3-methyl-2-
pentenoic acid
3-methylpentanoic
acid
hexanoic acid
heptanoic acid
octanoic acid
nonanoic acid
decanoic acid
undecanoic acid
dodecanoic acid
methyldodecanoic
acid
tridecanoic acid
tetradecenoic acid
methyltridecanoic
acid
tetradecanoic acid
pentadecenoic acid
methyltetradecanoic
acid
methyltetradecanoic
acid
methyltetradecanoic
acid
pentadecanoic acid
9-hexadecanoic acid
methylpentadecanoic
acid
hexadecanoic acid
heptadecenoic acid
methylhexadecanoic
acid
heptadecanoic acid
(Z)-3-methyl-2-
hexenoic acid
2-ethylhexanoic acid
n-heptanoic acid
2-methylheptanoic
acid
(E)-3-methyl-2-
hexenoic acid
phenol
y-C9 -lactone
n-octanoic acid
2-methyloctanoic
acid
4-ethylheptanoic
acid
7-octenoic acid
y-Clo-lactone
n-tetradecanol
n-nananoic acid
2-methylnonanoic
acid
4-ethyloctanoic acid
("goat acid")
n-hexanoic acid
n-decanoic acid
2-methyldecanoic
acid
4-ethylnonanoic acid
9-decenoic acid
n-hexadecanol
n-undecanoic acid
4-ethyldecanoic acid
(E)-3-methyl-2-
hexenoic acid
Octanoic acid
7-octenoic acid
Nonanoic acid
C9 -unsaturated acid
Decanoic acid
Undecanoic acid
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acid acid
11-
phenoxyundecanoic
acid
9,12-
octadecadienoic acid
9-octadecenoic acid
methylheptadecanoic
acid
octadecanoic acid
docosanoic acid
lactic acid
hexanedioic acid
heptanedioic acid
benzoic acid
4-hydroxybenzoic
acid
4-hydroxy-3-
methoxybenzoic
acid
5. CONCLUSIONS
Recent studies correlating mating behavior with MHC genetics suggest that odor may be
derived from an individual's DNA. In this study, the volatile signatures of skin
emanations, as part of a larger study including volatiles derived from both blood and
urine, were collected and characterized. A large variety of non-standardized collection
procedures for this biological fluid have been described in the literature, and it was
necessary to develop a robust, reproducible, and convenient collection protocol tailored
to the needs of this study. Several different collection protocols were attempted, but the
most useful protocol ended up being the rubbing of glass beads on the backs and palms of
hands as described in previous studies identifying mosquito attractants to human
hosts[26]. The next issue to address was sample preparation for the GC/MS instrument.
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Direct thermal desorption with cryofocusing ended up causing damage to the
chromatographic column and incurred additional difficulties with cellular contaminants
and instrument maintenance, while static headspace extraction did not provide a
significant instrument response distinguishable from noise. Solid phase microextraction
(SPME) of the volatile signature of the beads proved to be a better alternative, especially
for large sample sets. In addition, standardizing this extraction across all biological
samples (urine and blood also) allows for closer comparison of results as data sets are
expanded in the future.
An experiment was designed and conducted involving 4 unrelated individuals
who each donated approximately 30 samples of skin emanations, over a period of 30
days. The Correlogic genetic algorithm was applied to this data and several models were
produced. One model in particular achieved an overall classification accuracy of 98.3%.
This indicates that a stable underlying signature is present amongst the otherwise
variable, complex emanations produced over time. These results were confirmed with
PCA analysis. The PCA analysis, however, brought to light a problem in the alignment
algorithm that was effecting the clustering of the samples. The algorithm was modified
to include reference files for all four donors, and modeling was conducted again. Results
from these models show a reduction in the accuracy of classification, however further
adjustments need to be made to the alignment algorithm. In particular, the threshold
needs to be set higher so as to avoid an overabundance of landmarks. This abundance of
landmarks, usually correlated with a background signal of siloxanes, or another noisy
component, causes erratic fitting of the piecewise cubic spline approximation function. It
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is encouraging to note that the second round of PCA analysis indicated a more normal
and expected clustering pattern, and the artifact had been removed, i.e. clustering was
independent of donor in both aligned and unaligned analyses.
Samples from three sets of twins and from three other unrelated individuals have
been collected and MHC typed. Results from these samples consist of lists of identified
compounds through NIST library searching and suggest potential links with MHC
volatiles identified in other studies. In addition, these analyses provided interesting
insights into the potential of SPME extraction. Specifically, the issue of competitive
adsorption seemed significant. From the lists of compounds, no conclusive connections
can necessarily be made to MHC type, but certain volatiles seemed unique to each twin
set. In addition, some of the identified components, such as carboxylic acids, have been
correlated in other studies to MHC types in mice. Carboxylic acids are ubiquitous
products of lipid metabolism in many species and are known to associate with amino
acids which in turn can associate with the peptide binding groove in MHC products.
These represent the only set of identified compounds, in current literature, reliable traced
to MHC genetics in both urine and blood. The collection, extraction, and analysis
protocol presented here was shown to provide a robust signal from human skin
emanations, including the set of expected carboxylic acids, and was able to uniquely
classify four unrelated individuals using both PCA and genetic algorithm modeling.
Therefore, this protocol represents a viable method to be extended for more broad-
ranging, large sample-size MHC studies.
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6. FUTURE DIRECTIONS
6.1 SPME-FAIMS Experiments and Considerations for Potential Device Design
Some headway has been made recently on miniaturizing GC/MS for field use. The
FAIMS detector, while unproven in this application, is also a good candidate for
miniaturization. The FAIMS detector can detect a wide range of compounds, but
sometimes some initial separation is necessary. A SPME fiber may be an ideal
separation for this detector. The SPME phase is similar to that found in a
chromatographic column (PDMS). If the SPME were desorbed for analysis with a
temperature ramp, analytes would selectively leave the SPME phase at specific
temperature. All the studies so far have been conducted at high temperature, isothermal
desorption, and this idea has not been fully explored. A ramped desorption provides a
degree of separation that could be similar, if not as extensive, as a chromatographic
column-just the amount of separation the FAIMS detector needs. In addition, using the
SPME device in a non-equilibrium, transient extraction as mentioned above allows for
quick capture of volatiles and, especially with the DVB mixed phases, avoids competitive
adsorption which decreases the robustness of the signature extracted. A non-equilibrium,
transient extraction is ideal for field applications because the extraction time is on the
order of seconds, not minutes.
6.2 Potential Use in Medical Applications
The set of proteins found in serum, or the "serum proteome", has been the subject of
intense research for disease diagnosis. For example, the studies mentioned earlier,
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employing the Correlogic algorithm, focused on serum proteins and related metabolites
as markers for prostate and ovarian cancer[21, 22]. The identity and relative quantities of
"biomarkers" for a disease state has been the desired goal. Often, however, large high-
concentration serum proteins that enable the circulatory function of this fluid are
problematic for the analyst. They tend to obscure the low-concentration, critical
"biomarkers" and require special sample preparation steps, like affinity chromatography.
Skin emanations, on the other hand, are a filtrate of the blood to begin with, similar to
urine, and lack the high concentrations of serum specific proteins, like albumin, trypsin,
and immunoglobulin. Substances secreted on the skin are often metabolic wastes and
represent a unique mixture with great potential for disease diagnosis. Furthermore,
collection of this fluid, while currently not standardized, is non-invasive and convenient,
as its successful implementation in diagnosing cystic fibrosis proves.
1. INTRODUCTION
2. MATERIALS AND METHODS
3. RESULTS
4. DISCUSSION
5. CONCLUSIONS
6. FUTURE DIRECTIONS
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Figure 14: Sectioning of Socks for Sock Odors Experiment
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Figure 15: Diagram of SPME Extraction
Glass liner (4 mm Diam.) containing Glass Beads (3 mm Diam.)
General Method:
1. Beads are sealed in inlet
2. Inlet ramped to 250°C (5 min)
3. Oven remains at ambient (and
open) for first 10 minutes
To MSD 4. LiN2 bath removed
5. Oven temperature program
begins (3 temperature ramps)
Chromate
Liquid Nitrogen Bath
ographic Column
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Figure 16: Diagram of Instrument Setup for Thermal Desorption of Glass Beads followed
by Cryofocusing
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Figure 17: Dot Product Comparisons of Data for SPME versus CRYO Experiment
Table 1 1: List of Compounds for Donor 12 and Donor 13
Donor 12, Day 1 (07/02/04)
1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester
7-Acetyl-6-ethyl -1 1,,4,4-tetramethyltetralin
Butanoic acid
Cyclohexadecane
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Decanal
Dodecanoic acid
Hexanoic acid
Nonanal
Octanal, 2-(phenylmethylene)-
Donor 13, Day 1 (07/02/04)
1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester
5,9-Undecadien-2-one, 6,10-dimethyl-, (E)-
Decanal
Dodecanoic acid
Ethanol, 2-(2-ethoxyethoxy)-
n-Decanoic acid
Nonanal
Nonanoic acid
Table 12: List of Compounds for Donor 17 and Donor 18
Donor 17, Day 1 (07/02/04)
5,9-Undecadien-2-one, 6,10-dimethyl-, (E)-
7-Acetyl-6-ethyl-1 ,1 ,4,4-tetramethyltetralin
Cyclopentaneacetic acid, 3-oxo-2-pentyl-, methyl ester
Dodecanoic acid
Ethylene brassylate
Formamide, N,N-dibutyl-
Hexadecanoic acid, methyl ester
Isopropyl Myristate
Octanal, 2-(phenylmethylene)-
Donor 18, Day 1 (07/02/04)
1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester
2,6,10,14,1 8,22-Tetracosahexaene, 2,6,10,15,1 9,23-hexamethyl-, (all-E)-
5,9-Undecadien-2-one, 6,10-dimethyl-, (E)-
Butane, 1,1'-[oxybis(2,1-ethanediyloxy)]bis-
Cyclohexadecane
Cyclopenta[g]-2-benzopyran, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-
hexamethyl-
Dodecanoic acid
Hexanoic acid, 2-ethyl-, hexadecyl ester
Isopropyl Myristate
Naphthalene
Octanal, 2-(phenylmethylene)-
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Figure 18: NIST Library Spectral Comparisons with Peak Unique to Donor 12 (top) and
Donor 13 (bottom) when Compared to Donors 17 and 18
MATLAB Script for Alignment Algorithm:
function [ = AlignBlindLandmarks4pchip(varargin)
Use landmarks derived from 2 reference data sets to time align
another chromatogram to them.
I Usage for-mat is:
A l ignBI ndLandmarks4pchip ()
The thresholds are the minimum total ion abundance that you want to
use t o
% identify a peak. The higher the threshold, the fewer peaks
ident ified,
% MaxTimeOffset is the maximum allowable misalignment between files,
° Landmarks will not be checked for- identical ness between files
un e s
% thev are within this time offset value (in seconds).
% Min2:orr is the minimum correlation value of an m/z spectra from two
files t be considered identical.
87
7Q
% allowtime is the max time (sec) allowed between usable landmarks
when
% calculating the funcuional approximation.
6 Example of inputs:
% reffilel = 'grey 1Ointerp.bin';
% reffile2 = 'grey__0-3interp.bin
% reffile3 = 'grey 04interp.bin';
% reffile4 = 'grey 05interp.bin';
% filename = 'grey 02interp.bin';
% thresholdl = 600000;
% threshold2 = 600000;
% threshold3 = 600000;
% threshold4 = 600000;
% threshold5 = 600000;
% outputfile5 = 'grey 02align.bin';
% MaxTimeOffset = 20;
% MinCorr = 0.99;
% allowtime = 20:
%%% open the diary file
diaryName = strcat('diary_AlignBlindLandmarks2pchip_',
datestr(datevec(now),30), '.txt');
diary (diaryName);
fprintf('\n\n\n\n****** Beginning AlignBlindLandmarks2pchip at %s
******\n\n', datestr(datevec(now),0));
%%% define the number of parameters in each array
numParams = 14;
%%% check number of input arguments
if (nargin == 0)
fprintf('ERROR: AlignBlindLandmarks2() must have inputs.
Goodbye.\n\n');
diary off;
return;
end
%%% check validity of all input array arguments
for (ii = l:nargin)
if (length(varargin{ii}) -= numParams)
fprintf('ERROR: each bpskTest() input argument array must have
%d elements. Goodbye.\n\n', numParams);
diary off;
return;
end
end
%% sanitize all the input arguments
for (inpArgIdx = l:nargin)
reffilel = varargin{inpArgIdx}{l};
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reffile2 = varargin{inpArgIdx}{2};
reffile3 = varargin{inpArgIdx}{3};
reffile4 = varargin{inpArgIdx}{4};
filename = varargin{inpArgIdx}{5};
thresholdl = varargin{inpArgIdx})({6};
threshold2 = varargin{inpArgIdx}{7};
threshold3 = varargin{inpArgIdx})(8};
threshold4 = vararginfinpArgIdx}{9};
threshold5 = varargin{inpArgIdx}{10};
outputfile5 = varargin{inpArgIdx}{11};
MaxTimeOffset = varargin{inpArgIdx}{12};
MinCorr = varargin{inpArgIdx}{13};
allowtime = varargin{inpArgIdx}{14};
fprintf('\nProcessing task %d of %d with reffilel=%s, reffile2=%s,
reffile3=%s, reffile4=%s, filename=%s, thresholdl=%d, threshold2=%d,
threshold:3=%d, threshold4=%d, threshold5=%5, outputfile5=%s\n',
inpArgIdx, nargin, reffilel, reffile2, reffile3, reffile4, filename,
thresholdl, threshold2, threshold3, threshold4, threshold5,
outputfile5);
9% reference file #1
fidm = fopen(reffilel, 'r');
RTPtsm = fread(fidm,l,'long');
MZPtsm = fread(fidm,l,'long');
RTm = fread(fidm,RTPtsm, 'single');
MZm = fread(fidm,MZPtsm, 'single');
InterpIntensityMatrixm = fread(fidm,RTPtsm*MZPtsm, 'single');
fclose(fidm);
InterpIntensityMatrixm=reshape(InterpIntensityMatrixm,RTPtsm,MZPtsm);
CGraml = sum(InterpIntensityMatrixm');
plot(RTm,CGram), xlabel('RT, Seconds'), ylabel('Abundance ,
titlelnft ilem)
pause
% InterpIntensityMatrixm = sqrt(abs(InterpIntensityMatrixm));
% imagesc(MZm,RTm, InterpIntensityMatrixm), ylabel('RT,
Seconds'), xlabel('M/Z'), title(filenameli
pause
IMatrixl = InterpIntensityMatrixm;
MZ1 = MZm';
timel = RTm;
TIC1 = CGraml';
clear RTm MZm InterpIntensityMatrixm RTPtsm MZPtsm fidm
reference file #2
fidm = fopen(reffile2, 'r');
RTPtsm = fread(fidm,l,'long');
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MZPtsm = fread(fidm,l,'long');
RTm = fread(fidm,RTPtsm, 'single');
MZm = fread(fidm,MZPtsm,'single');
InterpIntensityMatrixm = fread(fidm,RTPtsm*MZPtsm,'single');
fclose(fidm);
InterpIntensityMatrixm=reshape(InterpIntensityMatrixm,RTPtsm,MZPtsm);
CGram2 = sum(InterpIntensityMatrixm');
% plot/RTm,CGram), xlabel('RT, Seconds'), ylabel('Abundance'),
title(infilem)
% pallse
% InterpIntensityMatrixm = sqrt (abs(InterpIntensityMatrixm));
% imagesc(MZm,RTm, InterplntensitMatrixm) , ylabel('P.T,
Seconds'), xlabel('M/Z'), title(infilem)
% pause
IMatrix2 = InterpIntensityMatrixm;
MZ2 = MZm';
time2 = RTm;
TIC2 = CGram2';
clear RTm MZm InterpIntensityMatrixm RTPtsm MZPtsm fidm
%% reference file #3
fidm = fopen(reffile3, 'r');
RTPtsm = fread(fidm,l,'long');
MZPtsm = fread(fidm,l, 'long');
RTm = fread(fidm,RTPtsm, 'single');
MZm = fread(fidm,MZPtsm,'single');
InterpIntensityMatrixm = fread(fidm,RTPtsm*MZPtsm, 'single');
fclose(fidm);
InterpIntensityMatrixm=reshape(InterpIntensityMatrixm,RTPtsm,MZPtsm);
CGram3 = sum(InterpIntensityMatrixm');
% plot(RTm,CGram), xlabel('RT, Seconds'), ylabel('Abundance'),
title(infilem)
% pause
% InterpIntensityMatrixm = sqrt(abs(InterpIntensityMatrixm));
% imagesc(MZm,RTm, InterplntensityMatrixm), ylabel('RT,
Seconds'), xlabel('M/Z'), titleinfilem)
% pause
IMatrix3 = InterpIntensityMatrixm;
MZ3 = MZm';
time3 = RTm;
TIC3 = CGram3';
clear RTm MZm InterpIntensityMatrixm RTPtsm MZPtsm fidm
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% r-eference ile #4
fidm = fopen(reffile4, 'r');
RTPtsm = fread(fidm,l,'long');
MZPtsm = fread(fidm,l,'long');
RTm = fread(fidm,RTPtsm,'single');
MZm = fread(fidm,MZPtsm, 'single');
InterpIntensityMatrixm = fread(fidm,RTPtsm*MZPtsm, 'single');
fclose(fidm);
InterpIntensityMatrixm=reshape(InterpIntensityMatrixm,RTPtsm,MZPtsm);
CGram4 = sum(InterpIntensityMatrixm');
% plot (RTm,CGram ) xlabel ( 'RT, Seconds' ! ylabel ( 'Abundance' )
ltle ( illf  .lem)
pause
InterpIntensityMatrixm = sqrt (abs(InterpIntensityMatrixm));
imagesc(MZm,RTm, InterpIntensityMatrixm), ylabel ( 'RT,
Seconds'), xlabel('M/Z'), title(infilem)
% pause
IMatrix4 = InterpIntensityMatrixm;
MZ4 = MZm';
time4 = RTm;
TIC4 = CGram4';
clear RTm MZm InterpIntensityMatrixm RTPtsm MZPtsm fidm
%% file to be aligned
fidm = fopen(filename, 'r');
RTPtsm = fread(fidm,l,'long');
MZPtsm = fread(fidm,l,'long');
RTm = fread(fidm,RTPtsm, 'single');
MZm = fread(fidm,MZPtsm, 'single');
InterpIntensityMatrixm = fread(fidm,RTPtsm*MZPtsm, 'single');
fclose(fidm);
InterpIntensityMatrixm=reshape(InterpIntensityMatrixm,RTPtsm,MZPtsm);
CGram5 = sum(InterpIntensityMatrixm');
plot RTm,CGram) , xlabel('RT, Seconds'), ylabel 'Abundance')
title (lnfilem)
pause
%i InterpIntensityMatrixm = sqrt(abs(InterpIntensityMatrixm )
imagesc(MZm,RTm, InterpIntensityMatrixm), ylabel]('RT,
Seconds' . xlabel 'M/Z') , title(infilem)
pause
IMatrix5 = InterpIntensityMatrixm;
MZ5 = MZm';
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time5 = RTm;
TIC5 = CGram5';
IMatrixl(:
IMatrixl(:
IMatrix2(:
IMatrix2(:
IMatrix3(:
IMatrix3(:
IMatrix4(:
IMatrix4(:
IMatrix5(:
IMatrix5(:
CGraml
CGram2
CGram3
CGram4
CGram5
,208)
,282)
,208)
,282)
,208)
,282)
,208)
,282)
,208)
,282)
= zeros
= zeros
= zeros
= zeros
= zeros
= zeros
= zeros
= zeros
= zeros
= zeros
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
(RTPtsm,l);
= sum(IMatrixl');
= sum(IMatrix2');
= sum(IMatrix3');
= sum(IMatrix4');
= sum(IMatrix5');
[PeakAmpl, PeakRT1, PeakIndsl]
thresholdl);
[PeakAmp2, PeakRT2, PeakInds2]
threshold2);
[PeakAmp3, PeakRT3, PeakInds3]
threshold3);
[PeakAmp4, PeakRT4, PeakInds4]
threshold4);
[PeakAmp5, PeakRT5, PeakInds5]
threshold5);
= FindPeaksV2(timel, TIC1,
= FindPeaksV2(time2, TIC2,
= FindPeaksV2(time3, TIC3,
= FindPeaksV2(time4, TIC4,
= FindPeaksV2(time5, TIC5,
%%%%%%%%%%%%%%%%%%%%%%%%%% %%%%%%%%%%%%%%%%%%%%%%
%Plot unaligned TICs, frame--by-frame
Frames = fix(length(time2)/10);
for n = 1:10
Inds = ((n-l)*Frames+l):(n*Frames);
figure (1); subplot(5,2,n);
plot(timel(Inds),TIC1(Inds),time2(Inds),TIC2(Inds),time3(Inds),TIC3(Ind
s),time4(Inds),TIC4(Inds),time5(Inds),TIC5(Inds)), xlabel('Retention
Time (sec) '), ylabel('Total Ion Abundance')
grid on%, leqendd('Sample 1','Sample 2', 'Sample 3','Sample
4','Sample 5')
end
% figure (1);
plot(timel,TICl,time2,TIC2time3,TIC3,time4~TIC4,time5,TIC5 ,
xlabel('Retention Time sec) '), ylabel('Total Ion Abundance')
% legend('Sample 1' 'Sample 2','Sample 3 'Sample 4','Sample
5'i. grid on
% %%%%%%%%%%%- %%%%%%,%%%%%%%%%%%
%Plot chromatogranm with landmarks circled
figure (2); plot(timel, TIC1, PeakRT1, PeakAmpl,'o'),
title(['Sample 1 - ',num2str(length(PeakIndsl)),' Landmarks'])
92
grid on, xlabel('Retention Time (sec) '), ylabel('Total Ion
Abundance'), legend('Chromatogram', 'Landmarks')
figure (3); plot(time2, TIC2, PeakRT2, PeakAmp2, 'o'),
title( ['Sample 2 - ',num2str(length(PeakInds2)),' Landmarks'])
grid on, xlabel('Retention Time (sec) '), ylabel('Total Ion
Abundance '), legend (' Chromatogram', 'Landmarks')
figure (4); plot(time3, TIC3, PeakRT3, PeakAmp3,'o'),
title( ['Sample 3 - ',num2str(length(PeakInds3)) , ' Landmarks'])
grid on, xlabel('Retention Time (sec) '), ylabel('Total Ion
Abundance') , legend ( 'Chromatogram', 'Landmarks')
figure (5); plot(time4, TIC4, PeakRT4, PeakAmp4, 'o'),
title( ['Sample 4 - ',num2str(length(PeakInds4)), ' Landmarks'])
grid on, xlabel('Retention Time (sec) ), ylabel('Total Ion
Abundance' ), legend( 'Chromatogram' , 'Landmarks')
figure (6); plot(time5, TIC5, PeakRT5, PeakAmp5, 'o'),
title( ['Sample 5 - ',num2str(length(PeakInds5)), ' Landmarks'])
grid on, xlabel('Retention Time (sec) '), ylabel('Total Ion
Abundance'), legend ( 'Chromatogram', 'Landmarks')
o%%%%%,,o %90~o~oso o% 0j-90j~oS-S oo%%%%9j%~%%%o o %9 % % % % ooo%%%%%%%
9 Take the landmarks in Sample 1 as the alignment reference, and
find
% offset to identical features in Sample 2
~s~~~~~%~~s%%%%%%%%%%%f
9j % % o o%
MaxTimeOffset = 20; %% max
tolerable misalignment. seconds
°% MinCcrr = 0.99;
LandmarkMatrix = zeros((length(PeakIndsl) +length(PeakInds2)), 7);
% LandmarkMatrix(:,l) = [PeakIndsl'; PeakInds2'];
°- LandmarkMatrix(:,2) = [PeakRTl'; PeakRT2'] ;
LandmarkMatrix (:, 3) = [PeakAmpi'; PeakAmp2'];
LandmarkMatrix = sortrows (LandmarkMatrix, [1] ) ;
Peaklnds = LandmarkMatrix(:, l) '
PeakRTs = LandmarkMatrix(:,2) ;
% PeakAmps = LandmarkMatrix (:,3) ';
for n = l:length(PeakRTs)
for m = l:length(PeakInds3)
if abs{PeakRTs(n) - PeakRT3(m)) < MaxTimeOffset
% Tracel = IMatrixl(PeakIndsl(n),:);
Trace2 = IMatrix2 (PeakInds2 (m),:);
% Corrcoef =(Tra(ei*Trace2' /sqrt ((Tracel*Tracel ) * (Trace2*Trace2 ' ) ;
Tracel = IMatrixl (PeakInds(n) -9): (Peakinds(n)+9 ) .);
Trace3 = IMatrix2( (PeakInds3 (m)-
C Peakln:Irds3 (m)-9, :9 )
% Tracel = Tracel mean(mean(Tracel));
% Trace2 = Trace2 mean(mean(Trace2) ;
%- (Corrcoef =
suln suinr ITrac(-el .*Trace3) ) /sqrt (sum(sum(Tracel . *Trace.l! *sum sum (Trace3 *
Trace3 i ) 
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% if Corrcoef > MinCorr
% %plot(MZ1, sum(Tracel),MZ2,sum(Trace2)) 
title([num2str(Corrcoef), ' I num2str(PeakRTl(n))j ,'
num2str(PeakRT2(m)) ]
% %pause
% figure (13); plot(MZ1,Trace,MZ2,Trace2);
%pause
% LandmarkMatrix (n,4)=PeakInds3 rmr);
% LandmarkMatrix(n, 5) =PeakRT3(m);
% LandmarkMatrix (n, 6)=PeakAmp3(m);
% LandmarkMatrix(n,7)=Corrcoef;
% end
% end
% end
% end
% LandmarkMatrix2l = LandmarkMatrix;
LandmarkMatrix = zeros(length(PeakIndsl),7);
LandmarkMatrix(:,l) = PeakIndsl';
LandmarkMatrix(:,2) = PeakRT1';
LandmarkMatrix(:,3) = PeakAmpl';
for n = l:length(PeakIndsl)
for m = l:length(PeakInds5)
if abs(PeakRTl(n) - PeakRT5(m)) < MaxTimeOffset
% TraceJ = IMatrixl(PeakIndsl(n) ,:);
% Trace2 - IMatrix2(PeakInds2(m),:);
% Corrcoef =
(Tracel*Trace2' ) /sqrt( (Tracel*Tracel')* (Trace2*Trace2' i ) ;
Tracel = IMatrixl((PeakIndsl(n)-9):(PeakIndsl(n)+9),:);
Trace5 = IMatrix5((PeakInds5(m)-9):(PeakInds5(m)+9),:);
% Tracel = Tracel - mean(mean(Tracel));
% Trace2 = Trace2 - mean(mean(Trace2));
Corrcoef =
sum(sum(Tracel.*Trace5))/sqrt(sum(sum(Tracel.*Tracel) ) *sum(sum(Trace5.*
Trace5)));
if Corrcoef > MinCorr
%plot(MZl,sum(Tracel),MZ2,sum(Trace2))
title([num2str(Corrcoef), ' num2str(PeakRTl(n)),
num2str (PeakR.T2 (n) ) 
%pause
%figure (13); plot(MZ1,Tracel,MZ2,Trace2);
%pause
LandmarkMatrix(n,4)=PeakInds5(m);
LandmarkMatrix(n,5)=PeakRT5(m);
LandmarkMatrix(n,6)=PeakAmp5(m);
LandmarkMatrix(n,7)=Corrcoef;
end
end
end
end
LandmarkMatrix5l = LandmarkMatrix;
LandmarkMatrix = zeros(length(PeakInds2),7);
LandmarkMatrix(:,l) = PeakInds2';
LandmarkMatrix(:,2) = PeakRT2';
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(Tra
sum(
LandmarkMatrix(:,3) = PeakAmp2';
for n = l:length(PeakInds2)
for m = l:length(PeakInds5)
if abs(PeakRT2(n) - PeakRT5(m)) < MaxTimeOffset
% Tracel = IMatrixl(PeakIndsl(n) ,:;
% Trace2 = IMatrix2(PeakInds2 (),:);
° Corrcoef -
iceltTrace2 /sqrt ( (Tracel*Tracel * (Trace2*Trace2' );
Trace2 = IMatrix2((PeakInds2(n)-9):(PeakInds2(n)+9),:);
Trace5 = IMatrix5((PeakInds5(m)-9):(PeakInds5(m)+9),:);
% Tracel = Tracel - mean(meanTracel));
% Trace2 = Trace2 - mean(mean(Trace2));
Corrcoef =
sum(Trace2.*Trace5))/sqrt(sum(sum(Trace2.*Trace2 )*sum(sum(Trace5.*
Trace5)));
if Corrcoef > MinCorr
%plot (MZl,sum(Tracel),MZ2, sum(Trace2),
title( [nurn2str(Corrcoef), ' ', num2str (PeakRT1 (n) ,'
num2str (PeakRT2 ((m) )
%pause
%figure (13); plot(MZ1,Tracel,MZ2,Trace2);
%pause
LandmarkMatrix(n,4)=PeakInds5(m);
LandmarkMatrix(n,5)=PeakRT5(m);
LandmarkMatrix(n,6)=PeakAmp5(m);
LandmarkMatrix(n,7)=Corrcoef;
end
end
end
end
LandmarkMatrix52 = LandmarkMatrix;
%%% %% %
LandmarkMatrix = zeros(length(PeakInds3),7);
LandmarkMatrix(:,l) = PeakInds3';
LandmarkMatrix(:,2) = PeakRT3';
LandmarkMatrix(:,3) = PeakAmp3';
for n = l:length(PeakInds3)
for m = l:length(PeakInds5)
if abs(PeakRT3(n) - PeakRT5(m)) < MaxTimeOffset
% Tracel = IMatrixl(PeakIndsl (n),:);
% Trace2 = IMatrix2(PeakInds2(m), :);
% Corrcoef =
tTracel*Trace2' ) /sqrt ( (Tracel*Tracel' )*Trace2*'Frace2' ) ;
Trace3 = IMatrix3((PeakInds3(n)-9):(PeakInds3(n)+9),:);
Trace5 = IMatrix5((PeakInds5(m)-9):(PeakInds5(m)+9),:);
% Tracel = Tracel - mean(rnean(Tracel)) 
% Trae2 = Trace2 mean(mean(Trace2));
Corrcoef =
sum(sum(Trace3.*Trace5))/sqrt(sum(sum(Trace3.*Trace3))*sum(sum(Trace5. *
Trace5)));
if Corrcoef > MinCorr
%plot(MZ1, sum (Tracei) ,MZ2, sum(Trace2) ,
t t le( (nun2str-(Coricoef) . num2sti (PeakPTI (n) ' 
rum2stt- I Pe kRT2 fm ) 
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%pause
6figure (.13); plot(MZI,I'racel,MZ2,Tracea2)
%pause
LandmarkMatrix(n,4)=PeakInds5(m);
LandmarkMatrix(n,5)=PeakRT5(m);
LandmarkMatrix(n,6)=PeakAmp5(m);
LandmarkMatrix(n,7)=Corrcoef;
end
end
end
end
LandmarkMatrix53 = LandmarkMatrix;
%%%%..%%
LandmarkMatrix = zeros(length(PeakInds4),7);
LandmarkMatrix(:,l) = PeakInds4';
LandmarkMatrix(:,2) = PeakRT4';
LandmarkMatrix(:,3) = PeakAmp4';
for n = l:length(PeakInds4)
for m = l:length(PeakInds5)
if abs(PeakRT4(n) - PeakRT5(m)) < MaxTimeOffset
% Tracel = IMatrixl(PeakIndsl (n) ,:);
0 Trace2 = IMatrix2(PeakInds2(m),:);
% Corrcoef =
(Tracel*Trace2')/sqrt ( (T racl*Tracel')* (Trace2*Trace2');
Trace4 = IMatrix4((PeakInds4(n)-9):(PeakInds4(n)+9),:);
Trace5 = IMatrix5((PeakInds5(m)-9):(PeakInds5(m)+9),:);
% Tracel = Tracel - mean(mean(Tracel));
% Trace2 = Trace2 - mean(mean(Trace2));
Corrcoef =
sum(sum(Trace4.*Trace5))/sqrt(sum(sum(Trace4.*Trace4))*sum(sum(Trace5.*
Trace5)));
if Corrcoef > MinCorr
%plot(MZl,sum(Tracel),MZ2,sum(Trace2)),
title([num2str(Corrcoef), ' num2str(PeakRTl(n)) ' '
num2str(PeakRT2(m))])
%pause
%figure !13 ) plot(MZ1,Tracel,MZ2,Trace2);
%pause
LandmarkMatrix(n,4)=PeakInds5(m);
LandmarkMatrix(n,5)=PeakRT5(m);
LandmarkMatrix(n,6)=PeakAmp5(m);
LandmarkMatrix(n,7)=Corrcoef;
end
end
end
end
LandmarkMatrix54 = LandmarkMatrix;
clear LandmarkMatrix;
LandmarkMatrix = [LandmarkMatrix51; LandmarkMatrix52;
LandmarkMatrix53; LandmarkMatrix54];
LandmarkMatrix = sortrows (LandmarkMatrix, [2,1]);
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%%9%o%%g%%%%%%%%%%%%%%%%%
% Sample-derived time arping function
%9%%%%o%%%S% %%%%%%%%%°%%%%%%%% %%t%% %% % %% %%%%%%%%%%%%%%%%3%%%%%%
I = find(LandmarkMatrix(:,4)); % dentify usable landmarks
Map = [LandmarkMatrix(I, 5) LandmarkMatrix(I, 2)-LandmarkMatrix(I,
5)];
Map = [min(time3) Map(l,2); Map; max(time3) Map(length(I),2)];
Map = [Map(l:(length(I)+l),:);
mean(Map((length(I)+l):(length(I)+2),:)) ;Map((length(I)+2),:)];
i=1;
while i<=(length(Map)-l);
if Map(i,:)==Map(i+l,:);
Map(i+l,:) = [];
end
if Map(i,l)==Map(i+l,l);
Map(i+l,l)=(Map(i+l,1)+0.01);
end
i=i+l;
end
% the below command will take Map (which contains the common landmarks
and time
% offset! and add "dummy" landmarks between two points that are far
% apart. These points will have the same offset as the second of the
two
% spread landmarks... This helps constrain the cubic spline function.
% allowtlme = 10; %max time allowed between usable
l andmarks
r = 1;
while r < (length(Map)-l)
if (Map(r+l,l)-Map(r,l)) > allowtime
Map = [Map(l:(r-l),:); (Map(r,l):(allowtime):Map(r+l,l))',
Map(r,2)*ones(ceil((Map(r+l)-Map(r))/(allowtime)),l); Map(r+l:end,:)];
end
r=r+l;
end
Adjust time axis using warping function
Plot functional approximations
6 § - ° 00 % 0 000 0 ; % % 360 O0 06 00 0 O0 00 % % %000 0 0 % %%o 0- 9
Xunique=Map(:,l); % added by JJA; 9 February 2005, because pchip
was jivino error the data abscissae should be distinct; the two
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comments below are from a suggest solution from the mathworks website,
searching for this error
Yunique=Map(:,2); Tb, i, j]=unique(x); % Remove duplicates
from x
[Bb,Yy,Zz]=unique(Xunique); %x55=interpl(b, yi), 5 5! % Obtain the
interpolated value at x=5.5 - this succeeds
pp = pchip(Bb,Yunique(Yy));
Delta = ppval(pp,time5);
% recommented the following out because I ran into the same
error
% again even with the higher threshold; this leads me to bel
the
% compound matrix of four ref files includes double entries
% pp = pchip(Map(:,l),Map(:,2)); % original code from
*2pchip.m; removed 'unique' call above because it seemed to be a
threshold too low problem
% Delta = ppval(pp,time5); % original code from
*2pchip.m with time3 --> time 5
pchip
ieve
%figure (5);
plot(Map(:,l),Map(:,2),'o',(0:max(Map(:, 1) ) ./(length(RTm)-
1):max(Map(:,l1))), pp), xlabel('Retention Time(sec)'), ylabel('RT
Sample 1 - RT Sample 4 (sec)')
% legend('Landmarks', 'Functional Approximation'), grid on
% pp=pp';
% RT3p = time5 + pp;
%6 pp = csape(Map(:,l),Map(:,2)) ; %cubic spline
% Delta = ppval(pp,timrne5);
figure (7); plot(Map(:,l),Map(:,2),'o',time5, Delta),
xlabel('Retention Time(sec)'), ylabel('RT Sample 1-4 - RT
(sec) ')
Sample 5
grid on, legend('Landmarks', 'Functional Approximation')
RT5p = time5 + Delta;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Plot aligned TICs frame-by-frame
%%%%%%%%%%0%%%90%%%%%%%%%%%%%%%%%%%%%%%0%%%%%%%%%%%%%%%%%%%%%%%
Frames = fix(length(time2)/10);
for n = 1:10
Inds = ((n-l)*Frames+l):(n*Frames);
figure (8); subplot(5,2,n);
plot(timel(Inds),TIC1(Inds),time2(Inds),TIC2(Inds),time3(Inds),TIC3(Ind
s),time4(Inds),TIC4(Inds),RT5p(Inds),TIC5(Inds)), xlabel('Retention
Time (sec)'), ylabel('Total Ion Abundance')
grid on%, legend('Sample 1','Sample 2, 'Sample 3'.,Sample
4','Sample 5')
end
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figure (6);
plot: (t ime , TICl, tLme2,TIC2,time3,TIC3, time4,TIC4,RT3p,TIC3)
xlabel ('Alilgned Retention Time sec) ') , ylabel ('Total on Abundance' 
9 legend'Sample 1','Sample 2', 'Sample 3' 'Sample 4, Sample
5') grid on
%Chec to make sure all looks good before
%pause
%%% save results to binary file
outputFid5 = fopen(outputfile5,
outputting to file
(outputfile!
w');
COUNT = fwrite(outputFid5,length(RT5p), 'long');
COUNT = fwrite(outputFid5,length(MZ5),'long');
count = fwrite(outputFid5, RT5p, 'single');
fprintf('Wrote %d single-precision values to file %s\n', count,
outputfile5);
count = fwrite(outputFid5, MZ5, 'single');
fprintf('Wrote %d single-precision values to file %s\n', count,
outputfile5);
count = fwrite(outputFid5, IMatrix5, 'single');
fprintf('Wrote %d single-precision values to file %s\n', count,
outputfile5);
fclose(outputFid5);
end for inpArgIdx = l:nargin)
%% wrap it up
fclose('all');
fprintf('\,n\n****** End AlignBlindLandmarks2 at %s *****\n\n\n\n\n\n',
datestr(datevec(now),O));
diary off;
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